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Abstract  
 
 
The microsomal triglyceride transfer protein (MTP) is a protein that plays a major role in 
the synthesis of apolipoprotein B-containing lipoproteins. It is located in the lumen of the 
endoplasmic reticulum (ER) and is involved in the loading of nascent lipoproteins with 
lipids. In humans, MTP has been shown to be involved in the biogenesis of 
apolipoprotein B100 in the liver and apolipoprotein B48 in the small intestine. MTP and 
apoB are also expressed in the human placenta, suggesting that this organ is also able to 
synthesize and secrete apoB-containing lipoproteins. During mouse embryonic 
development, MTP is expressed in the yolk sac, as well as in liver and small intestine. 
MTP was not detected in cardiac or renal tissue of mouse embryos. In the laying hen, it 
has been shown that MTP is expressed in liver, small intestine, and kidney. Chicken liver 
synthesizes and secretes also apoB100-containing lipoproteins, but the small intestine 
lacks apoB48. Instead of apoB48, chicken small intestine secretes portomicrons, which 
are apoB100-containing lipoproteins.  
As MTP is expressed in the yolk sac of mouse, in the human placenta, and in various 
tissues involved in lipid metabolism in the laying hen, it could be assumed that MTP is 
also present in the yolk sac of the developing chicken embryo. The chicken yolk sac is 
responsible for the supply of the growing embryo with nutrients contained in the yolk. 
Using quantitative PCR and western blot analysis, it could be shown here that MTP is 
expressed in the yolk sac, its expression starting at the end of the first trimester of 
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embryonic development, and it is still present in the yolk sac in the early post-natal 
period. Immunohistochemistry and western blot analysis indicated that MTP is expressed 
in the inner layer of the yolk sac, the endodermal epithelial cells (EECs). Further, pulse 
chase analysis showed that apoB100 is synthesized and secreted by cultured yolk sac. It 
is therefore likely that MTP plays an important role in de novo synthesis of lipoproteins 
in this organ. In addition to the yolk sac, liver, small intestine, and kidney of chicken 
embryos at different developmental stages were included into the analysis on MTP 
expression. In liver and kidney of chicken embryos, MTP mRNA and protein could be 
detected from the middle of the second trimester of embryonic development on. MTP 
expression in the chicken small intestine starts in the third trimester of embryonic 
development. Immunohistochemistry of chicken embryonic liver, small intestine, and 
kidney confirmed the presence of MTP in the respective tissues and also gave insights 
into the localization of MTP in these tissues.  
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Zusammenfassung 
 
 
Das mikrosomale Triglycerid Transfer-Protein (MTP) ist ein Proteinkomplex, der bei der 
Synthese von ApolipoproteinB-enthaltenden Lipoproteinen eine wichtige Rolle spielt. 
MTP befindet sich im Lumen des Endoplasmatischen Reticulums (ER) und ist in die 
Beladung von entstehenden Lipoproteinen mit Lipiden involviert. Es wurde gezeigt, dass 
MTP an der Biogenese von ApolipoproteinB100 in der Leber und von 
ApolipoproteinB48 im Dünndarm des Menschen beteiligt ist. MTP und apoB werden 
auch in der humanen Plazenta exprimiert, was ein Hinweis darauf ist, dass dieses Organ 
auch fähig ist, apoB-enthaltende Lipoproteine zu synthetisieren und zu sekretieren. 
Während der Embryonalentwicklung von Mäusen wird MTP im Dottersack exprimiert. 
Weiters ist es auch in der Leber und im Dünndarm von Mausembryonen vorhanden, 
konnte allerdings weder in deren Herz- noch Nierengewebe nachgewiesen werden. In der 
Legehenne wurde gezeigt, dass MTP in der Leber, im Dünndarm und in der Niere 
exprimiert wird. Die Leber von Hühnern synthetisiert und sekretiert apoB100-enthaltende 
Lipoproteine, aber dem Dünndarm fehlt apoB48. Statt apoB48 sekretiert der Dünndarm 
von Hühnern Portomicronen, die auch zu den apoB100-enthaltenden Lipoproteinen 
gehören.  
Da MTP im Dottersack von Mäusen, in der menschlichen Plazenta und in verschiedenen, 
in den Lipidmetabolismus involvierten Geweben der Legehenne exprimiert ist, konnte 
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vermutet werden, dass MTP auch im Dottersack des sich entwickelnden Hühnerembryos 
vorhanden ist. Der Dottersack von Hühnern ist verantwortlich für die Versorgung des 
wachsenden Embryos mit Nährstoffen, die der Dotter enthält. Mittels quantitativer PCR 
und Western Blot Analyse konnte hier gezeigt werden, dass MTP vom Ende des ersten 
Trimesters der Embryonalentwicklung an im Dottersack exprimiert ist. Aber auch in den 
ersten Tagen nach dem Schlüpfen ist MTP im Dottersack noch vorhanden. 
Immunhistochemie und Western Blot Analyse ergaben Hinweise darauf, dass MTP in der 
inneren Schicht des Dottersacks, den endodermalen epithelialen Zellen (EECs) exprimiert 
wird. Weiters konnte mit Pulse Chase Experimenten gezeigt werden, dass kultivierte 
Dottersack-Stücke apoB synthetisieren und sekretieren. Dieser Befund legt nahe, dass 
MTP eine wichtige Rolle in der de novo Synthese von Lipoproteinen im Dottersack 
spielt. Neben dem Dottersack wurden auch Leber, Dünndarm und Niere von 
Hühnerembryonen verschiedenster Entwicklungsstadien in die Untersuchungen der 
MTP-Expression miteinbezogen. In der Leber und der Niere von Hühnerembryonen 
konnten MTP mRNA und Protein von der Mitte des zweiten Trimesters der 
Embryonalentwicklung an detektiert werden. Im Dünndarm beginnt die Expression von 
MTP im dritten Trimester der Embryonalentwicklung. Immunhistochemische Analysen 
von Leber, Dünndarm und Niere von Hühnerembryonen bestätigten die Expression von 
MTP im jeweiligen Gewebe und gaben teilweise auch Aufschlüsse über die Lokalisation 
von MTP in diesen Geweben.  
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1. Introduction 
 
 
1.1. The large lipid transfer protein superfamily 
 
The microsomal triglyceride transfer protein (MTP) is a member of the large lipid 
transfer (LLT) protein (LLTP) superfamily. Proteins belonging to the LLTP superfamily 
are involved in mediating the circulatory lipid transport in animals. In addition to MTP 
(or MTP-like LLTPs), there are two more major families of LLTPs, namely 
apolipoproteinB (apoB)-like LLTPs and vitellogenin (Vtg)-like LLTPs. These proteins 
vary in their major lipid binding sites (LLT module and amphipatic secondary structures) 
and are therefore able to bind hundreds of different lipid molecules.  
Beside common characteristics, such as lipid transport, each family has different 
functions:  
 
• ApoB is present in vertebrates and it is responsible for postprandial lipid uptake 
and lipid redistribution in the body.  
• Vtg is the major yolk protein found in females of most egg-laying animals, non-
mammalian vertebrates and invertebrates and supplies the developing oocyte with 
nutrients, including lipids.  
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• MTP is present in vertebrates and invertebrates, and has been shown to enhance the 
biosynthesis of other LLTPs, as demonstrated for apolipoproteins and Vtg. 
(Smolenaars et al. 2007) 
 
LLTPs seem to be limited to animals, leading to the suggestion that this superfamily 
evolved at the beginning of animal evolution. Vertebrates encode MTP, apoB, and, 
except in mammals, one or more Vtgs, thus humans have only apoB and MTP. 
(Smolenaars et al. 2007) 
 
All members of the LLTP superfamily share the LLT module, which is located at the N 
terminus of almost every LLTP. Apart from this LLT module, LLTPs vary to a great 
extent in size and organization. The smallest of the LLTPs is MTP with around 890 
amino acids (aa), whereas other LLTPs are made up of up to 4.500 aa (apoB). (Figure 
1.1) 
 
 
Figure 1.1. Members of the LLTP superfamily.  
This figure illustrates the structural organization of LLTPs, showing that the LLT module is 
located at the N terminus of the proteins and that the lipid binding domain vary to a great extent in 
size. (adapted from Shelness and Ledford. 2005)  
 
The LLT module is made up of four major structural elements in all LLTPs (Figure 
1.2.A) These four elements consist of one α-helical bundle and three β-sheets, which are 
arranged in a way to form binding sites for homodimerization (Vtg) and 
heterodimerization (MTP with protein disulfide isomerase (PDI) and apoB) as well as 
lipid binding and lipid transfer. (Smolenaars et al. 2007) 
β-sheet α-helical lipid binding 
MTP 
Vtg 
ApoB 
~ 890 aa 
~ 1700 aa 
~ 4500 aa 
N 
N 
N 
LLT module 
 
 
 
 11 
1.2. Structure, localization, functions and regulation of MTP 
 
1.2.1. Structure and localization of MTP 
 
It was shown that active MTP consists of two non-covalently bound polypeptides, which 
are the 97 kDa M-subunit and the 55 kDa P-subunit. The P-subunit is the ubiquitous 
endoplasmatic reticulum (ER) resident enzyme PDI and its disulfide isomerase activity is 
not required to support the function of the MTP complex. The M-subunit requires the P-
subunit for its solubility, its retention in the ER, and for lipid-transfer acitivity. The two 
subunits are held together by non-covalent interactions. (Hussain et al. 2003. J. Lipid. 
Res.)  
The M-subunit consists of four structural elements (Figure 1.2.A) and the following three 
functional domains (Figure 1.2.B):  • lipid transfer domain  
• apoB binding domain  
• membrane association domain  
 
 
Figure 1.2. Structural and functional domains of the M-subunit of MTP.  
A. Structural domains: the M-subunit consists of 3 β-sheets and 1 helical domain. B. Functional 
domains: apoB binding, lipid transfer, and membrane association domains. (Hussain et al. 2003. 
Front. Biosci.)  
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1.2.1.1. The lipid transfer domain 
 
The lipid transfer domain plays an essential role in the assembly of lipoproteins by two 
independent mechanisms. First, MTP can take up lipids from the ER membrane and 
transfer them to nascent apoB. Several rounds of transfer would lead to the formation of a 
primordial lipoprotein particle. Insufficiently lipidated apoB is recognized by heat shock 
proteins, ubiquitinylated, and targeted to degradation. Second, the lipid transfer domain 
might be involved in the formation and stabilization of lipid droplets, effecting the 
formation of lipoprotein particles. (Figure 1.3) (Hussain et al. 2003. Front. Biosci.)  
 
 
Figure 1.3. Lipid transfer activity.  
Nascent apoB is associated with the ER membrane. MTP, bound to the ER membrane, picks up 
lipids from the membrane and transfers them to apoB. Inhibiton of lipid transfer leads to 
ubiquitinylation and heat-shock protein binding enhancing the degradation of apoB. (Hussain et al. 
2003. Front. Biosci.)  
 
1.2.1.2. The apoB binding domain 
 
The N-terminus of apoB is exposed to the lumenal side of the ER. Through binding of 
MTP to this N-terminus, it could release nascent apoB from the ER membrane liberating 
apoB´s hydrophobic binding domains and making them available for lipidation. Further, 
MTP binding to apoB could promote specific transfer of lipids to nascent apoB instead of 
futile transfer of lipids between membranes. After extensive lipidation and formation of 
an intermediate lipoprotein, MTP will be released, leading to formation of a primordial 
lipoprotein particle. Inhibition of the apoB-MTP interaction may increase the degradation 
of apoB. (Figure 1.4) (Hussain et al. 2003. Front. Biosci.)  
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Figure 1.4. ApoB binding activity.  
MTP interacts with nascent apoB leading to partial dislocation of apoB from the ER membrane. 
This provides a hydrophobic region in apoB for MTP to deliver lipids. Inhibition of apoB-MTP 
interaction could result in apoB degradation. (Hussain et al. 2003. Front. Biosci.) 
 
1.2.1.3. The membrane association domain 
 
The membrane association domain may be involved in the formation and stabilization of 
lipid droplets. MTP bound to these droplets could advance the maturation of lipoprotein 
assembly by delivering lipids as a bole. Lipid-associated MTP has a higher affinity for 
apoB and therefore promotes the biogenesis of primordial lipoprotein particles. Inhibition 
of the membrane association domain of MTP may decrease lipid droplet formation in the 
lumen of the ER and therefore impairs core expansion of the primordial particles. (Figure 
1.5) (Hussain et al. 2003. Front. Biosci.)  
 
 
Figure 1.5. Membrane binding activity.  
MTP molecules associate with lipid droplets and stabilize them favoring lipid transfer. Inhibition 
of this interaction may decrease the number of lipid droplets in the ER lumen and further impairs 
core expansion of primordial particles. (Hussain et al. 2003. Front. Biosci.) 
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1.2.3. Functions of MTP 
 
The major functions of MTP are its chaperone and lipid transfer activities during the 
formation of apoB-containing lipoproteins, as previously described. In this context, it is 
interesting to note that MTP has binding sites and lipid transfer activity for both 
phospholipids and neutral lipids, such as triglycerides and cholesterol esters. (Shelness 
and Ledford. 2005)  
Beside its role in apoB lipoprotein assembly, MTP is also involved in CD1d (cluster of 
differentiation 1d) biosynthesis. CD1d is a major histocompatibility complex class I 
homolog that presents lipid and glycolipid antigens to natural killer (NK) T cells, which 
are able to rapidly produce cytokines early in an immune response. This molecule has a 
hydrophobic cleft for harboring and presenting lipid antigens and it is present on the 
surface of antigen presenting cells. CD1d is synthesized in the ER, where it associates 
with membrane lipids. Later on, these lipids are exchanged with antigenic self lipids or 
lipids of microbial origin.  
Recent findings showed that CD1d physically interacts with MTP and the inhibition of 
MTP decreases cell surface expression of CD1d. Therefore, lipid antigen presentation is 
inhibited and NK T cell mediated immune response does not occur. In the ER, MTP 
directly transfers phospholipids to the antigen-binding site of CD1d and acts as a 
chaperone as it does for apoB-lipoprotein assembly. (Hussain et al. 2008) 
 
1.2.4. Regulation of MTP 
 
To characterize the molecular mechanisms controlling MTP gene transcription, human 
and hamster MTP gene promotors were analyzed. MTP transcription is initiated at a so 
called initiator sequence 30 basepairs (bp) downstream of the TATA box. There is a high 
sequence conservation 200 bp 5´ to the transcription start site leading to the suggestion 
that important regulatory elements are present therein.  
Both, human and hamster MTP promotors contain consensus recognition sequences for 
hepatocyte-specific trans-factors HNF-1 and HNF-4, an AP-1 recognition sequence, and 
a negative response element for insulin. HNF-4 is an activator of genes involved in lipid 
metabolism such as apoA-I, apoC-III, and apoB, and it is a member of the steroid 
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hormone receptor superfamily of transcription factors. Some members of this superfamily 
respond to fatty acids. The sterol regulatory element (SRE) in the human and hamster 
promotors was shown to slightly upregulate MTP expression by sterols. In contrast, 
insulin negatively regulates MTP gene transcription. (Hagan et al. 1994)  
 
It has been further investigated, whether MTP mRNA levels are influenced by diet. 
Hamsters were fed different diets, leading to the finding, that a high fat diet increases 
mRNA and protein levels of MTP in intestine and liver, accompanied by significant 
changes in plasma cholesterol and plasma triglyceride levels. (Lin et al. 1994) 
 
 
1.3. MTP in humans 
 
In humans, apoB and MTP are involved in the secretion of lipoproteins by the liver 
(apoB100) and the intestine (apoB48). MTP´s function is the transfer of neutral lipids 
onto nascent apoB leading to the formation of a lipoprotein particle for secretion. These 
lipoproteins enable the supply of peripheral organs with energy, fat-soluble vitamins and 
essential fatty acids. (Shelton et al. 2000)  
 
1.3.1. Abetalipoproteinemia 
 
Genetic deficiency of MTP results in the autosomal recessive disease of 
abetalipoproteinemia. It is caused by mutations in the gene for the 97 kDa M-subunit of 
MTP. Most of the mutations found in the MTP gene of abetalipoproteinemia patients lead 
to truncated proteins devoid of function, but also some missense mutations are known 
that cause a milder form of the disease. In patients suffering from abetalipoproteinemia, 
apoB is synthesized but cannot form lipoproteins and therefore is degraded. Defects 
involving apoB lead to homozygous hypobetalipoproteinemia, a very similar condition. 
(Raabe et al. 1998; Tarugi et al. 2007) 
In case of abetalipoproteinemia, the absorption and peripheral delivery of vitamins A and 
E are impaired, causing the pathophysiology of this inherited disease. Therapeutic 
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supplementation of these vitamins improves or even prevents complications when 
therapy started early in the course of the disease (Shelton et al. 2000). The plasma lipid 
profile of abetalipoproteinemia patients is characterized by extremely low plasma levels 
of total cholesterol, VLDL, and LDL, and an almost complete absence of apoB (Tarugi et 
al. 2007). In addition, fat accumulations in the intestine and hepatic steatosis have been 
observed in affected patients (Hussain and Bakillah. 2008).  
 
1.3.2. MTP as a target in hyperlipidemias 
 
As MTP is a chaperone for the assembly of lipoproteins, it seemed conceivable that 
inhibiting MTP activity might result in lower plasma cholesterol levels. Hyperlipidemias 
are risk factors of various cardiovascular and metabolic disorders, caused by reduced 
catabolism or increased production of lipoproteins. Statins reduce plasma cholesterol, but 
also cause adverse coronary events. Therefore, the development of new drugs is 
necessary. MTP, which is crucial for the synthesis of lipoproteins, seems to be an ideal 
candidate target of new drugs. Several MTP antagonists have been shown to inhibit 
triglyceride transfer activity in vitro, to suppress lipoprotein assembly and secretion in 
vivo, and to decrease plasma lipid levels in humans and animals. Major side effects of 
MTP inhibition first appear in intestine and liver in form of steatorrhea and diarrhea due 
to lack of chylomicron assembly by enterocytes, as well as upregulation of liver enzymes 
specific for liver damage. In liver, MTP inhibition also causes a higher accumulation of 
neutral lipids, which might be toxic. (Hussain and Bakillah. 2008)  
 
To lower cellular cholesterol levels, inhibition of hepatic 3-hydroxy-3-methyl-glutaryl 
(HMG) CoA reductase might be helpful. There are also many other approaches to avoid 
side effects of MTP inhibitors to ensure their safety and efficacy, such as liver X receptor 
(LXR) agonists, which would enhance the efflux of free cholesterol. The development of 
such drugs could be very useful in the treatment of various lipidemias and metabolic 
disorders. (Hussain and Bakillah. 2008)  
Extensive in vitro studies with cultured cells and MTP inhibitors showed that MTP 
activity does not appear to be limiting for the synthesis and assembly of apoB-containing 
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lipoproteins. Rather, the availability of lipids (triglycerides) limits the production of 
VLDL and chylomicrons. (Dixon et al. 1990; Pan et al. 2001)  
 
1.3.3. MTP during human embryonic development 
 
Embryos affected with abetalipoproteinemia or homozygous hypobetalipoproteinemia do 
not lead to fetal loss in humans, whereas homozygous apoB or MTP knockout mouse 
embryos are not viable. This could be due to the different function of the yolk sac in 
humans and rodents. In humans, the yolk sac seems to be only a vestigial remnant, 
whereas in rodents it has important nourishing functions during the critical phase before 
the establishment of placental, and it expresses the apoB gene and synthesizes apoB-
containing lipoproteins. ApoB is also expressed in the human yolk sac, but as it is only a 
rudimentary organ, it looses its nutritional function very early in embryogenesis when the 
placenta is established. (Madsen et al. 2004) 
 
In humans, the placenta, responsible for the full supply of the embryo with nutrients, 
expresses apoB and MTP. It was shown that it also synthesizes and secretes apoB100-
containing lipoproteins. Formation and secretion of apoB lipoproteins is the most 
efficient way for delivery of lipids and carrying all the included nutrients such as 
essential lipids from the liver and intestine to peripheral organs or from the maternal 
circulation to that of the embryo. Beside liver and intestine, the placenta could be added 
to the list of apoB producing organs. ApoB is also expressed in heart myocytes. In 
mouse, apoB mRNA was also detected in kidney (Madsen et al. 2004). As the kidney of 
the chicken plays also a major role in lipoprotein production it seems plausible that it 
expresses MTP too (Ivessa et al. in revision).  
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1.4. MTP during mouse embryonic development 
 
MTP is essential for the formation of apoB lipoproteins. ApoB knockout mice showed 
exencephalus and death in midgestation mouse embryos. Obviously, apoB-lipoprotein 
assembly in the developing embryonic yolk sac is required for development of the mouse 
embryo. (Gordon et al. 2000)  
 
Before the establishment of the maternal-fetal circulation, apoB-lipoproteins could serve 
as a means of transport of essential lipids and lipid-soluble vitamins. As MTP is required 
for the formation of these lipoproteins, it has been suggested that knockout of MTP leads 
to the same phenotype. In fact, most of the homozygous MTP knockout mouse embryos 
died around embryonic day 14 and those who remained viable showed exencephalus 
(Raabe et al. 1998). These embryos showed severe neurodevelopmental defects and a 
lack of hematopoiesis, a phenotype very similar to apoB homozygous knockout mice 
(Gordon et al. 2000). Obviously, embryonic apoB lipoprotein assembly is critical for 
normal embryonic development of the nervous and the hematopoietic system in mice.  
 
During the early stages of embryonic development, before establishment of the placental 
circulation, the yolk sac of rodents and other small mammals exposes its absorptive 
surface towards the uterine decidual tissue absorbing maternal nutrients including 
lipoproteins. These lipoproteins must be unloaded on the apical side of the yolk sac to 
enable their repackaging and re-secretion on the embryonic side of the membrane. Supply 
with nutrients by the yolk sac is especially important before the neural tube closes and 
before a functional circulatory system is established in the growing embryo. The uptake 
of lipoproteins by the yolk sac requires a set of lipoprotein receptors, including the low 
density lipoprotein (LDL) receptor gene family, as well as the scavenger receptor class B 
type I (SR-BI), a high density lipoprotein (HDL) receptor. Within the yolk sac, apoB and 
MTP mediate the repackaging of the lipids into lipoproteins (Herz and Farese 1999). 
Without apoB lipoprotein assembly, the supply of the embryo with lipids and lipid-
soluble vitamins would not be possible. It was shown, that in the yolk sac of homozygous 
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apoB or MTP knockout mice lipids accumulated in large vacuoles within the yolk sac and 
are not transported to the growing embryo (Gordon et al. 2000).  
 
Expression of MTP was also detected in liver and intestine of adult mice. In the liver, 
MTP was expressed at a higher level in the hepatocytes around the portal vein, and in 
intestine the expression was restricted to the enterocytes lining the villi.  
In mouse embryos, MTP is first expressed in the yolk sac, followed by the primordial 
liver and subsequently in the developing intestinal tract. Further, the mouse yolk sac 
endoderm was characterized as a lipoprotein-secreting organ. (Terasawa et al. 1999)  
 
 
1.5. Chicken MTP 
 
Chicken MTP consists of 893 aa, it has a typical amino-terminal signal sequence with a 
predicted cleavage site between aa 19 and 20 and two consensus sites for N-linked 
glycosylation at aa 175 and 551. Compared to the chicken 97 kDa M-subunit with 893 aa, 
those of human, bovine, and murine consist of 894 aa residues and the one of hamster 
contains even 895 aa. Sequence homology analyses of chicken and human MTP showed 
that the two most conserved regions are located between aa 519 to 576 and 663 to 734 
whereas the most N- and C- terminal regions are less conserved. (Ivessa et al. in revision)  
 
MTP expression analyses in the laying hen showed, that the expression level of the 
protein is much higher in small intestine than in liver and kidney. It was also shown, that 
estrogen-treatment of roosters had no influence on the expression level of MTP. Further 
in vitro cell culture experiments using the estrogen-responsive leghorn male hepatoma 
(LMH)-2A cell line also confirmed that MTP expression is not influenced by estrogen or 
derivatives. (Ivessa et al. in revision)  
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1.6. Embryonic development of the chicken 
 
1.6.1. Oocyte formation and fertilization 
 
Before embryonic development can start, the oocyte has to mature. The oocyte is a single 
massive cell filled with lipid-rich droplets and proteinaceous granules, the cytoplasm 
being restricted to the germinal disc, which is located at one pole of the cell. Maturation 
of the oocyte occurs in the ovary of the laying hen, where lipids, including VLDL and 
Vtg, synthesized by the maternal liver, are incorporated into the growing cell. After the 
synthesis in the liver, VLDL (apoB, apoVLDL-II) and Vtg are transported via the 
bloodstream to the oocyte and are easily taken up by receptor-mediated endocytosis. 
After incorporation into the oocyte, the yolk precursors VLDL and Vtg are 
proteolytically modified. ApoB is cleaved into a series of smaller polypeptides, whereas 
Vtg is cleaved at a specific site, giving rise to two proteins, phosvitin and lipovitellin. 
After ovulation, which takes place every 25 hours, the ovum is released from the ovary 
and enters the oviduct. Movement of the ovum down the oviduct is driven by peristaltic 
contractions. Fertilization occurs in the upper part of the oviduct, the infundibulum, 
followed by sequential addition of albumen proteins, shell membranes and shell 
formation in the lower part (Figure 1.6). (Speak et al. 1998; Moran 2007)  
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Figure 1.6. Ovary and oviduct of the laying hen  
(chickscope.beckman.uiuc.edu.jpg)  
 
1.6.2. Early embryonic development 
 
At the time of laying, the blastodisc with a diameter of about 4 mm is formed and floats 
on the surface of the yolk mass. Lipids, proteins, vitamins, and trace elements are pre-
packaged in the egg and are required for the formation and growth of the embryo.  
Extraembryonic tissue, including amniotic, chorioallantoic, and yolk sac membranes, are 
formed during the early stages of embryonic development, because their functions are 
essential for growth (Figure 1.7).  
The chorioallantoic membrane lines the inner surface of the shell membranes and 
mediates the exchange of O2 and CO2 by its dense blood capillary system. Further, it 
mobilizes Ca2+ of the shell to fulfill the embryo’s needs for bone formation.  
The yolk sac membrane is also characterized by a high vascularization, and it grows 
outward from the embryo engulfing the yolk. Its function is the uptake of lipids from the 
yolk, their processing and transfer to the embryonic circulation. (Speak et al. 1998) 
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Figure 1.7. 10-day-old chicken embryo.  
The embryo is connected to the yolk sac via the omphalomesenteric vein and artery. The yolk sac 
engulfs the yolk, providing the embryo with nutrients. The chorioallantoic membrane is pervaded 
with a dense blood capillary system for the exchange of O2 and CO2. 
 
1.6.4. The yolk sac 
 
The yolk sac membrane can be divided into two layers: the outer mesoderm, which 
performs a supportive role and the inner endoderm of columnar cells, responsible for yolk 
absorption. The apical surface of these endodermal epithelial cells (EECs) represents the 
absorptive surface of the yolk sac. To enable sufficient uptake of nutrients and supply of 
the embryo with them, these cells form folds, invaginations, and villus-like projections 
into the yolk. In addition, the EECs themselves form microvilli to enlarge the absorptive 
surface. The yolk sac is also pervaded by a network of capillaries, which emanate from 
the villi and feed into the major omphalomesenteric veins, which enter the portal 
circulation of the embryo through the yolk stalk (Figure 1.7).  
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Electron microscopy studies of the yolk sac gave some insights into the process of lipid 
uptake by the EECs. Lipid droplets and proteinaceous granules of the yolk are engulfed 
or phagocytosed at the apical surface of the EECs, or they are taken up in coated-pit 
regions via receptor-mediated endocytosis. It has been observed that inside the cells, the 
vesicles form large apical vacuoles. They fuse and give rise to large lipid-rich yolk 
droplets, which occupy the bulk of the cytoplasmic space. Inside these droplets, lipids are 
hydrolyzed and further processed.  
Furthermore, the yolk-derived lipids are re-esterified in the ER and the Golgi, illustrated 
by the presence of lipid-rich spherules. This re-esterification may be intimately connected 
with lipoprotein assembly. The formation of lipoproteins requires apoB, the major 
structural protein of chylomicrons and VLDL, which associates with newly synthesized 
neutral lipids in the lumen of the ER, a process that requires MTP.  
Finally, after processing the lipids are transported to the basal membrane of the EECs via 
exocytotic vesicles, which fuse with the cytoplasmic membrane and release the contents 
of the spherules into the vascular system of the yolk sac. (Speak et al. 1998)  
 
1.6.5. The liver 
 
The omphalomesenteric veins feed into the portal system. Yolk sac-derived VLDL enters 
the embryonic circulation and primarily supplies the liver. As the lipoprotein lipase 
(LPL)-activity of embryonic liver is very low, most of the lipoproteins emerge from this 
tissue with little or no modification. VLDL catabolism is initiated in capillaries, which 
permeate the adipose tissue, heart and muscle. In these tissues LPL is more active. The 
remnant lipoproteins are removed from the bloodstream by receptor-mediated uptake into 
the liver, leading to massive accumulation of cholesterol esters (CE) in the hepatocytes, 
appearing as large lipid droplets in the cytoplasm. During embryonic development, 
continuous accumulation of CE in the liver occurs. Overspill of CE from the liver passes 
into the small intestine and finally ends up in the yolk sac. Thus, the yolk sac changes 
color, from yellow to green, towards the end of embryonic development.  
It seems only logical that the lipid components of the remnants also undergo lysosomal 
hydrolysis and re-esterification in the ER of the embryonic liver, similar to the 
 
 
 
 24 
modification of yolk-derived lipids by the yolk sac. This suggestion is supported not only 
by the presence of endocytic vesicles in the embryonic liver, but also by the expression of 
apoB mRNA in this organ. In addition, it has been shown by incubation of embryonic 
liver with labeled amino acids, followed by immunological detection that it synthesizes 
and secretes apoB. (Speak et al. 1998)  
 
1.6.6. The gastrointestinal system 
 
The gastrointestinal system is not yet completely developed and functional in the chicken 
embryo. The embryo orally takes up the albumen-amniotic mixture, which is partially 
absorbed by enterocytes in the duodenum and jejunum. These enterocytes of the 
embryonic villi are capable of fluid and macromolecular transfer to supply the growing 
vascular system with albumen proteins. (Moran. 2007)  
 
1.6.7. The kidney 
 
In the chicken, the kidney is a major lipoprotein-producing organ. The proximal tubule 
epithelium of the kidney expresses also receptors for uptake of various ligands, including 
apolipoproteins. This direct uptake of lipids in the proximal tubules may indirectly affect 
plasma and tissue lipid metabolism. It was shown that male chick kidney and rooster 
kidney express apoB RNA and synthesize apoB100. Further, it is known that laying hen 
kidney also expresses MTP, which is necessary for apoB-synthesis. Formation of apoB 
lipoproteins is an evolutionarily conserved system to effectively remove bulk lipids from 
cells. Therefore, apoB secretion could be a way for assembly and re-secretion of lipids 
from renal proximal tubule epithelial cells to the circulation in form of lipoproteins. 
(Ivessa et al. in revision; Moestrup et al. 2005; Walzem et al. 1999) 
 
1.6.8. Late embryonic development and hatching 
 
The days before hatching, the yolk sac is completely retracted into the body of the 
embryo. So the newly hatched chick has about 5 g of residual yolk serving as nutrient 
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supply for the first days of its life. First food ingestion does not occur till the third day 
after hatching, and by day five after hatching, the remnant yolk sac is just a vestigial 
structure. (Speak et al. 1998)  
In contrast to the yolk sac, which degenerates, the liver can get rid of its massive 
accumulation of CE by production and secretion of apoB- and apoAI-containing 
lipoproteins. Further, it starts to express lipolytic enzymes for the recycling of ingested 
food lipid components. (Speak et al. 1998; Tarugi et al. 1994)  
Regarding the gastrointestinal system, enterocytes are arising from the crypts of the 
intestine and provide competence for digestion and absorption of nutrients. Within two 
weeks after hatching, the whole intestine is fully functional. (Moran. 2007) 
 
 
1.7. The role of EECs 
 
At the level of lipid content and fatty acid composition, distinct differences between the 
yolk contents and the embryonic plasma can be observed, and there are also differences 
between the structures and lipid contents of the major lipoprotein classes. (Noble and 
Cocchi. 1990)  
The occurrence of resynthesis and reassembly of VLDL in the yolk sac has been 
emphasized by biochemical analyses of yolk VLDL and embryonic VLDL. Yolk VLDL 
contains cathepsin D-generated apoB fragments and apoVLDL-II, while embryonic 
VLDL contains apoB100 and lacks apoVLDL-II. (Hermann et al. 2000)  
 
ApoB100 and apoVLDL-II are the two major apolipoproteins contained in VLDL in the 
hen, which are taken up into the growing oocyte via receptor-mediated endocytosis. 
ApoB100 mediates receptor binding, whereas apoVLDL-II is a lipoprotein lipase 
inhibitor and therefore assures full delivery of VLDL to the yolk. In the oocyte, apoB100 
is proteolytically cleaved and stored as so called yolk VLDL. (Hermann et al. 2000) 
 
The EECs, lining the inner surface of the yolk sac, are supposed to take up VLDL 
particles from the yolk via receptor-mediated endocytosis. Uptake studies with 
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fluorescently labeled yolk VLDL showed that cultured EECs actively take up 
lipoproteins. VLDL synthesis within the yolk sac requires MTP, which is also expressed 
therein. Further, apoB100 containing VLDL particles are present in the 
omphalomesenteric vein, which is part of the embryonic circulation. The lack of 
apoVLDL-II therein makes these lipoproteins substrates for embryonic lipoprotein lipase, 
allowing the embryo to derive energy from the yolk. (Hermann et al. 2000)  
 
Taken together, these findings confirm the resynthesis and reassembly of yolk VLDL in 
the yolk sac and the important role of EECs in the uptake and processing of lipoproteins. 
It only remains to be demonstrated the secretion of newly synthesized apoB100 
lipoproteins by these cells.  
 
 
1.8. Aim of the thesis 
 
During my diploma thesis, I wanted to investigate the role of MTP in embryonic and 
extraembryonic tissues. As the growing chicken embryo depends on the yolk as the 
unique source of energy, it nourishes on the lipids present therein. Findings about MTP, 
crucial for lipoprotein synthesis during this important period of life, could give further 
insights in its role in lipoprotein synthesis. Yolk sac, liver, small intestine, and kidney 
were the principal tissues to be analyzed with various methods to gain insights into the 
expression profile of MTP protein and mRNA, as well as its localization in various 
tissues, and its role in de novo synthesis of apoB-containing lipoproteins by the yolk sac.  
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2. Materials and Methods 
 
 
2.1. Chemicals and enzymes 
 
Chemicals obtained from AppliChem, Fluka, Merck, Riedel-de Haen, Roche, Sigma-
Aldrich and Starlab were used for the production of buffers, solutions, and media.  
 
The following polymerases were used: 
 SUPERScriptTM RNase H- Reverse Transcriptase II (200 U/ µl) from Invitrogen 
 High Fidelity Enzyme Mix (5 U/ µl) from Fermentas 
 
 
2.2. Bacterial strains and vector systems 
 
Strain One Shot TOP10 Chemically Competent E.coli 
Genotype 
 
F-mcrA Δ(mrr-hsdRMS-mcrBC)φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(araleu)7697galU galK rpsL (StrR) endA1 nupG 
Reference/ source Invitrogen 
Table 2.1. Properties of chemically competent E.coli TOP10 bacteria 
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Vector pCR2.1-TOPO 
Size 3931 bp 
Genotype characteristics 
 
 
LacZalpha fragment, M13 reverse priming site, MCS, T7 
promotor/ priming site, M13 forward priming site, f1 origin, 
kanamycin resistance, ampicillin resistance, pUC origin 
Reference/ source Invitrogen, TA cloning kit 
Table 2.2. Properties of T/A cloning vector 
 
 
Figure 2.1. Genetic map of the pCR 2.1-TOPO cloning vector  
(www.invitrogen.com)  
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2.3. Animals 
 
Derco brown laying hens and roosters were purchased from Heindl Co. (Vienna, 
Austria). The animals were maintained on layer´s mash with free access to water and feed 
under a daily light period of 16 hours. Fertilized eggs were incubated at 37,7°C and 55% 
relative humidity (from day 1 to day 19 of embryonic development) and 80% relative 
humidity (from day 20 until hatching) for a chosen time period.  
 
 
2.4. Oligonucleotide primers 
 
The designed oligonucleotide primers were synthesized by MWG-Biotech AG, 
Ebersberg, Germany.  
 
Name Sequence Annealing°C 
T/A cloning vector    
M13fw 5´- G TAA AAC GAC GGC CAG -3´ 51.7 
M13rev 5´- CAG GAA ACA GCT ATG AC -3´ 50.4 
Chicken MTP   
MTP_fw2 5´- GCTAGCCTTTTCCAGCTAC -3´ 56.7 
MTP_rev1 5´- ATTTTGGCACCTGTTTTTCG - 3´ 54.0 
Chicken ggRS17    
ggRS17_fw 5´- ACACCCGTCTGGGCAACGACT -3 63.7 
ggRS17_rev 5´- CCCGCTGGATGCGCTTCATCA -3´ 63.7 
Standard primer    
Oligo (dT) 5´-TTT (TTT)2-4 TTT-3´   
Table 2.3. List of oligonucleotide primers used for PCR 
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2.5. Antibodies 
 
Name Epitope Source 
Anti-chicken MTP-B peptide Rabbit 
Anti-chicken ApoB-100 protein Rabbit 
Anti-rabbit IgG peroxidase conjugated (Sigma) Rabbit IgG Goat 
Anti-rabbit IgG biotin conjugated (Sigma) Rabbit IgG Goat 
Table 2.4. List of anitbodies 
 
 
2.6. Molecular biological methods: DNA 
 
2.6.1. cDNA synthesis 
 
Total RNA was used as a template for the synthesis of cDNA, which was carried out 
using SUPERScriptTM Rnase H- Reverse Transcriptase II from Invitrogen. The following 
components were mixed together and incubated at 65°C for 5 minutes and subsequently 
put on ice:  
 10 µl RNA in Rnase-free ddH2O 
 1 µl dNTPs (10 mM each)  
 1 µl Oligo(dT) (0.5 µg/ µl)  
 
Afterwards, 4 µl First Strand Buffer and 2 µl 0.1M DTT were added followed by an 
incubation at 42°C for 2 minutes. Finally, 1 µl Superscript II reverse transcriptase (200 
U/ µl) was added and mixed gently. The cDNA synthesis was performed at 42°C for 50 
minutes and stopped by an incubation at 70°C for 15 minutes. Finally, the cDNA was 
stored at -80°C.  
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2.6.2. Polymerase chain reaction (PCR) 
 
All components listed up below were mixed together in a sterile PCR-tube, which was 
kept on ice. Depending on the actual experiment, different primers were used. The PCR-
program was also adapted depending on the best conditions for the current experiment.  
 
cDNA 1 µl 
10× High Fidelity PCR Buffer containing 15 mM MgCl2 from 
Fermentas  2.5 µl 
Forward primer (20 pmol/ µl)  0.5 µl 
Reverse primer (20 pmol/ µl)  0.5 µl 
DMSO 1 µl 
dNTPs (10 mM each) 0.5 µl 
High Fidelity Enzyme Mix (5 U/ µl) from Fermentas 0.25 µl 
ddH2O 18.75 µl 
Table 2.5. Standard mixture of chemicals and enzymes used for PCR 
 
Step Temperature Time Number of Cycles 
Lid temperature 99°C   
Initial denaturation 94°C 5 min  
Denaturation 94°C 1 min 40 
Annealing x°C x min  
Extension 72°C x min  
Last Extension 72°C 10 min  
Pause 4°C   
Table 2.6. Standard conditions used for PCR 
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2.6.3. DNA gel electrophoresis 
 
50× TAE: 
Tris/ HCl     2 M 
Acetic acid     1 M 
Ethylenediaminetetraacetic acid (EDTA) 0.1 M 
 
Ethidium bromide stock solution: 
10 mg/ ml in ddH2O 
 
5× DNA loading buffer: 
100% Glycerine 5 ml 
0.5 M EDTA  2 ml 
50× TAE  12 ml 
ddH2O   3 ml 
Bromphenol blue or Xylene cyanol 
 
DNA fragments were separated by gel electrophoresis using a 1% agarose gel containing 
ethidium bromide (40 µg/ 100 ml) with a voltage of 100 V for 30 minutes. The samples 
were mixed with an adequate amount of 5× DNA loading buffer and loaded onto the gel 
together with 5 µl of GeneRulerTM 1 kb Plus DNA Ladder from Fermentas. The DNA 
fragments were visualized with ultraviolet light.  
 
2.6.4. DNA gel extraction with Xact DNA gel extraction kit from GenXpress 
 
The DNA-fragment was excised from the agarose gel with a sharp scalpel and put into an 
Eppendorf-tube. Then, 400 µl of Binding Buffer II were added to the gel. Further, the gel 
slice was incubated at 55°C for 10 minutes. During this incubation, the tube was vortexed 
several times. Thereafter, the mixture was added to the Xact column followed by 
incubation at room temperature for 2 minutes. The column was centrifuged for 2 minutes 
at 10.000 rpm in an Eppendorf centrifuge and the flow-through was discarded. The 
 
 
 
 33 
membrane-bound DNA was washed twice by addition of 500 µl of Wash Solution, 
followed by centrifugation as described above. The column was centrifuged 2 minutes 
once more to remove any residual Wash Solution. Then, the column was placed in a 
clean 1.5 ml tube and 40 µl of pre-warmed (55°C) Elution Buffer were added to the 
center of the membrane. The column was incubated at room temperature for 2 minutes 
and finally the DNA was eluted by another centrifugation. The DNA was stored at -20°C.  
 
2.6.5. T/A-cloning 
 
For the ligation, the TOPO TA Cloning® Kit from Invitrogen was used. 4 µl of purified 
DNA were mixed with 1 µl of salt solution and 1 µl of PCR 2.1 TOPO-vector followed 
by an incubation for 5 minutes at room temperature. 2 µl of the ligation reaction were 
used for the transformation.  
 
2.6.6. Transformation of competent Escherichia coli (E.coli) cells 
 
Luria Broth plates containing kanamycin (LB-Kan plates): 
Peptone from Casein 10 g 
Yeast extract  5 g 
NaCl   10 g 
Agar-Agar  12 g 
ddH2O ad 1000 ml 
Kanamycin  100 µg/ ml 
 
LB-Kan plates containing X-Gal: 
50 µl of X-Gal solution (50 mg/ ml) were plated on LB-Kan plates.  
 
2 µl of the ligation were mixed with 50 µl of competent E.coli cells and put on ice for 30 
minutes, followed by an incubation at 42°C for 30 seconds. Then, the mix was put on ice 
 
 
 
 34 
again for 2 minutes. For regeneration of the E.coli cells 250 µl of SOC-medium from 
Invitrogen were added.  
The mixture was incubated for 1 hour at 37°C with vigorous shaking. Finally, 50 µl and 
150 µl were plated on LB-Kan/ X-Gal plates and incubated over night at 37°C. White 
colonies were analyzed for containing the correct insert by DNA mini preparation, 
restriction enzyme digestion, and agarose gel electrophoresis.  
 
2.6.7. Mini preparation of plasmid DNA 
 
Luria Broth medium containing ampicillin (LB-Amp): 
Trypton 10 g 
Yeast extract 5 g 
NaCl  10 g 
ddH2O ad 1000 ml 
Ampicillin 100 µg/ ml 
 
FastPlasmidTM Mini Kit from 5Prime was used for the preparation of plasmid DNA. All 
centrifugation steps were carried out in an Eppendorf microcentrifuge.  
White E.coli colonies were picked from LB-Kan/ X-Gal plates and used for inoculation 
of 4 ml LB-Amp. 1.5 ml of this E.coli culture were centrifuged in an Eppendorf-tube at 
14.000 rpm for 1 minute. Then, the medium was decanted and the pellet was resuspended 
in 400 µl ice-cold Complete Lysis Solution, followed by vortexing for 30 seconds. 
Afterwards, the lysate was incubated at room temperature for 3 minutes. After the 
incubation, the lysate was transferred to a Spin Column Assembly and centrifuged for 1 
minute at 14.000 rpm. The column was washed once by adding 400 µl Wash Buffer and 
an additional centrifugation. Then, the column was centrifuged once more to dry it. 
Finally, the column was put into a Collection Tube and the DNA was eluted by adding 40 
µl ddH2O and centrifuging 1 minute at full speed. The eluted DNA was stored at -20°C.  
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2.6.8. DNA sequencing 
 
For sequence analysis mini-preparations of plasmid DNA ware sent to Agowa Genomics 
(Berlin, Germany).  
 
2.6.9. Quantitative real-time PCR 
 
Quantitative real-time PCR was carried out using the Light Cycler® 480 system and the 
Light Cycler® FastStart DNA Master SYBR Green I Kit from Roche. First, the cDNA 
was diluted 1:10 with ultraPURETM Distilled Water RNase, DNase free from GIBCO. 
Furthermore, a serial dilution from 10-1 to 10-9 of the purified PCR product was made 
which was used as internal standard.  
Then, a mastermix was made and put together with the cDNA and the dilutions into a 
Light Cycler® Multiwell plate 96 from Roche.  
 
ddH2O 4.5 µl 
Forward Primer (20 pmol/ µl) 0.75 µl 
Reverse Primer (20 pmol/ µl) 0.75 µl 
Light Cycler® 480 SYBR Green I Master Mix 7.5 µl 
cDNA/ purified PCR product 1.5 µl 
Table 2.7. Standard mixture of chemicals and enzymes for qPCR 
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Step Temperature Time Number of cycles 
Initial denaturation 95°C 10 min 1 
Denaturation 95°C 15 sec 40 
Annealing 68°C/ 67°C 15 sec   
Elongation 72°C 13 sec/ 10 sec   
Flourescence Measuring 79°C 3 sec   
Melting curve 95°C 10 sec 1 
  65°C/ 75°C 20 sec   
  98°C* 1 sec   
Cooling 95°C 1 sec 1 
  50°C 1 sec   
Table 2.8. Standard program used for qPCR with chicken MTP primers.  
*The temperature increases continuously from 65°C up to 98°C and the fluorescence intensity 
is measured 5 times per °C. Italic: Changes in time and temperature using chicken RS17 
primers. 
 
 
2.7. Molecular biological methods: RNA 
 
2.7.1. Isolation of total RNA 
 
Highly pure RNA for cDNA synthesis was isolated using the NucleoSpin® RNA II kit 
from Macherey-Nagel. All centrifugation steps were carried out in an Eppendorf 
microcentrifuge.  
First, 35 mg of frozen tissue were homogenized in 350 µl buffer RA1 in a sterile glass 
potter. Thereafter, the homogenate was transferred into a 1.5 ml tube and 3.5 µl β-
mercaptoethanol were added. The homogenized tissue was vortexed vigorously. The 
mixture was poured into a NucleoSpin filter unit, which was placed in a collection tube 
and centrifuged for 1 minute at 14.000 rpm. After this, 350 µl ethanol were added to the 
flow-through and the lysate was loaded onto a NucleoSpin RNA II column, which was 
placed in a 2 ml centrifuge tube. The mixture was centrifuged at 10.000 rpm for 1 minute. 
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Then, 350 µl Membrane Desalting Buffer were added to the column followed by another 
centrifugation at 14.000 rpm for 1 minute. In the meantime, 10 µl DNase I and 90 µl 
DNase reaction buffer were mixed and then added to the center of the membrane. After 
an incubation of 15 minutes at room temperature, 200 µl buffer RA2 were added to the 
column and the column was centrifuged at 10.000 rpm for 1 minute. After the first 
washing step, the membrane was washed another time with 600 µl buffer RA2 and a third 
time with 250 µl buffer RA3, whereas the centrifugation at the third washing step 
occurred at 14.000 rpm for 2 minutes. Finally, the column was placed in a nuclease-free 
Eppendorf-tube and the RNA was eluated with 40 µl RNase-free ddH2O by 
centrifugation at 14.000 rpm for 1 minute. After measuring the RNA-concentration the 
samples were stored at -80°C.  
 
2.7.2. Determination of RNA concentration 
 
The RNA concentration was determined with the ND-100 Spectrophotometer from 
peqlab.  
 
 
2.8. Molecular biological methods: protein 
 
2.8.1. Preparation of membrane protein extracts 
 
Buffer A:  
Tris/ HCl, pH 8 20 mM 
CaCl2    1 mM 
NaCl   150 mM 
Complete, EDTA-free (Protease inhibitor cocktail tablets) from Roche 
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Buffer B: 
Tris maleate, pH 6 250 mM 
CaCl2    2 mM 
Complete, EDTA-free (Protease inhibitor cocktail tablets) from Roche 
 
To 1 g of frozen or fresh tissues prepared from chicken embryos of different 
developmental stages or laying hens, 5 ml buffer A were added and the tissue was 
homogenized with polytron three times for 15 seconds. In the meantime, the homogenate 
was kept on ice as much as possible.  
Thereafter, the homogenate was centrifuged at 5.000 rpm in the SS34 rotor from Sorvall 
in the Sorvall® RC 5C Plus centrifuge for 10 minutes. Then, the supernatant was 
transferred into a fresh tube and centrifuged again at 50.000 rpm in the TLA 100.3 rotor 
from Beckman in the OptimaTM TLX Ultracentrifuge from Beckman for 1 hour. After 
this centrifugation, the supernatant was discarded and lipids were removed using a wipe.  
Then, the pellet was resuspended in 3 ml of buffer A, using first a 18 gge needle, 
followed by a 22 gge needle. The suspension was centrifuged again at 50.000 rpm in the 
TLA 100.3 rotor from Beckman in the OptimaTM TLX Ultracentrifuge from Beckman for 
1 hour. After this, the supernatant was discarded again and the pellet was resuspended in 
625 µl of buffer B using again the 18 gge and the 22 gge needles. Then, 50 µl 4M NaCl 
were added and the sample was sonicated for 30 seconds at 50% with the Bandelin 
Sonoplus HB 70 sonicator. Finally, 325 µl ddH2O and 250 µl 5% Triton X-100 were 
added followed by a final centrifugation at 50.000 rpm in the TLA 100.3 rotor from 
Beckman in the OptimaTM TLX Ultracentrifuge from Beckman for 1 hour. Then, the 
supernatant was carefully aliquoted and stored at -80°C.  
 
2.8.2. Determination of protein concentration 
 
Protein concentration of membrane protein extracts was determined with the method of 
Bradford using Assay Dye Reagent Concentrate from BioRad. 10 µg of BSA were mixed 
with 1 ml of the concentrate and used as standard. 1 µl of each membrane protein extract 
was also mixed with 1 ml concentrate. After 5 minutes of incubation at room temperature 
 
 
 
 39 
the absorbance of the samples were measured with an UV sptectrophotometer at 595 nm. 
The protein concentration was calculated as follows:  
 
 
 
 
 
 
2.8.3. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
1× Electrophoresis buffer: 
Tris/ HCl 250 mM 
Glycine 192 mM 
SDS  0.1% 
 
4× Laemmli buffer (non reducing): 
Glycerol  1.2% 
SDS   6% 
Tris/ HCl pH 7.5 20 mM 
Bromphenolblue 
ddH2O ad 20 ml 
 
4× Laemmli buffer (reducing): 
Glycerol  1.2% 
SDS   6% 
Tris/ HCl pH 7.5 20 mM 
Dithiothreitol (DTT)  50 mM 
Bromphenolblue 
ddH2O ad 20 ml 
 
 
OD Standard 
µg Standard 
µl Sample 
OD Sample . =  µg/µl Protein 
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 Stacking gel        Separation gel        Gradient gel 
 4% 6% 10% 4.5% 18% 
ddH2O (ml) 1.525 2.675 2.025 1.92 0.43 
1.5 M Tris pH8.8 (ml) - 1.25 1.25 0.81 0.81 
0.5 M Tris pH 6.8 (ml) 0.625 - - - - 
30% PAA (ml) 0.325 1 1.65 0.495 1.98 
10% SDS (µl) 25 50 50 32.25 31.5 
10% APS (µl) 12.5 25 25 25 25 
TEMED (µl) 5 5 5 2.5 2.5 
Table 2.9. Composition of SDS-gels 
 
SDS-PAGE was performed using the equipment from BioRad. All components of the 
separation gel were mixed and pipetted into the gel unit. In case of the gradient gel, 
ddH2O, Tris buffer, acrylamid, and 10% SDS were mixed and pipetted into the gradient 
maker. After addition of APS and TEMED, the two solutions were poured into the gel 
unit generating a gel ranging from 18% at the bottom to 4.5% at the top of the gel. The 
gel was overlaid with isopropanol, which was removed after polymerization of the gel. 
Then the stacking gel was mixed and poured onto the separation gel. The comb was 
inserted immediately. After polymerization of the stacking gel, the comb was removed 
and the slots were rinsed with ddH2O. Thereafter the gel was put into the buffer chamber, 
which was filled with electrophoresis buffer.  
 
The samples were mixed with an adequate amount of reducing or non-reducing Laemmli 
buffer. Under reducing conditions, the samples were incubated for at least 5 minutes at 
95°C, which is not necessary under non-reducing conditions. Then, the samples were 
loaded onto the gel together with 15 µl of Precision Plus Protein Standard from BioRad. 
The separation of the proteins occurred at a constant voltage of 130V for a time period 
depending on the size of the protein to be analyzed.  
The gel was either used for Coomassie stain, Silver stain, or Western blot analysis.  
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2.8.4. Coomassie stain 
 
Coomassie blue: 
Acetic acid    10% 
Isopropanol    25% 
Coomassie Brilliant Blue R250 0.287 g 
ddH2O ad 1000 ml 
 
Destain solution: 
Methanol 30% 
Acetic acid 10% 
Diluted with ddH2O 
 
SDS-gels were incubated in Coomassie Blue for 1 hour at room temperature. Then, 
Coomassie Blue was decanted and the gel was covered with Destain Solution for at least 
1 hour at room temperature and further dried in a gel vacuum dryer.  
 
2.8.5. Western blot analysis 
 
1× Blotting Buffer: 
Tris/ HCl 25 mM 
Glycine 193 mM 
 
10× TBS: 
NaCl  1.37 M 
KCl  0.027 M 
Tris/ HCl 0.25 M 
With HCl to pH 7.4 
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1× TBS-T: 
1:10 dilution of 10× TBS 
Tween-20 0.01% 
 
Ponceau S: 
Ponceau S  0.2% 
Trichloracetic acid 3% 
Diluted with ddH2O 
 
Blocking solution: 
5% non-fat dry milk powder in 1× TBS-T 
 
Detection solution: 
Enhanced chemiluminescent (ECL) from Pierce 
 
Wet blotting: 
For wet blotting the blotting equipment from BioRad was used. Proteins were transferred 
from the SDS-gel to HybondTM-C Extra for optimized protein transfer-membranes from 
Amersham Bioscience.  
First, three Whatman papers were soaked with 1× Blotting Buffer and put onto the 
blotting unit. Then, the nitrocellulose membrane was applied to the Whatman papers, 
followed by the gel, and three more wet Whatman papers. To avoid air bubbles a Falcon 
tube was rolled over the stack. Then the blotting unit was connected to the power supply 
and blotting was performed for 1 and a half hour at 200 mA per gel.  
After blotting, the nitrocellulose membrane was stained with Ponceau S. After destaining 
with ddH2O, the bands of the samples and of the standard were visible. The bands of the 
standard were marked with a pen.  
 
Immunoblot: 
The nitrocellulose membrane was blocked with 5% non-fat dry milk in 1× TBS-T for at 
least 1 hour at room temperature. Then, the primary antibody was diluted in 5% non-fat 
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dry milk in 1× TBS-T and the nitrocellulose membrane was incubated with it over night 
at 4°C gently shaking.  
The next day, the nitrocellulose membrane was washed 3 times with 1× TBS-T for 5 
minutes. Thereafter, the membrane was incubated with an HRP-conjugated secondary 
antibody diluted in 5% non-fat dry milk in 1× TBS-T for 1 hour at room temperature 
gently shaking. Then, the nitrocellulose membrane was washed another 3 times with 1× 
TBS-T for 5 minutes.  
 
Detection: 
Enhanced chemiluminescence (ECL) from Pierce was used to visualize the proteins on 
the nitrocellulose membrane. The peroxide solution and the luminal/ enhancer solution 
were mixed 1:1 and the nitrocellulose membrane was covered with this mixture and 
incubated for 2 minutes at room temperature. Thereafter, the membrane was put into an 
exposure cassette and CL-XPosureTM Films from Pierce were exposed to the signal in the 
dark room.  
 
2.8.6. Pulse chase 
 
1× PBS:  
NaCl  137 mM 
KCl  2.7 mM 
Na2HPO4 10 mM 
KH2PO4 2 mM 
Diluted with ddH2O, pH 7.4 
 
Starvation medium: 
RPMI 1640 without L-Glutamine, L-Methionine, L-Cystine and L-Cysteine from MP 
Biochemicals 
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Pulse medium: 
Starvation medium containing 250 µCi/ ml NEG-772 EasytagTM Express Protein 
Labeling Mix, [35S]  
 
Chase medium:  
DMEM with high glucose (4.5 g/ l), with D-Valine, without L-Valine, without L-
Glutamine from PAA    500 ml 
FCS      10% 
AB/AM antibiotic, antimyotic from Gibco 5 ml 
L-Glutamine (200 mM)   5 ml 
L-Methionine (400 mM)   20 µl 
L-Cysteine (400 mM)   20 µl 
 
Protein A sepharose: 
Protein A SepharoseTM CL-4B from GE Healthcare 
 
Loading buffer:  
4× Laemmli buffer (reducing) 
 
Cultured tissue-pieces and cells were washed twice with 1× PBS and incubated in an 
appropriate amount of starvation medium for 30 minutes in an incubator (37°C and 5% 
CO2). Then, the medium was removed and the tissue-pieces and cells were exposed to the 
pulse medium for 1 hour in an incubator (37°C and 5% CO2). After the pulse phase, the 
specimens were covered with chase medium, which was retained after 5 minutes, 1, 2, 
and 4 hours.  
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2.8.7. Immunoprecipitation 
 
10× PBS:  
NaCl  1.37 M 
KCl  27 mM 
Na2HPO4 100 mM 
KH2PO4 20 mM 
Diluted with ddH2O, pH 7.4 
 
1× PBS:  
1:10 dilution of 10× PBS with ddH2O 
 
The samples (media from pulse chase analysis) were centrifuged for 15 minutes at 4°C 
and 15.000 rpm in the 1K15 centrifuge from Sigma. Then, the supernatant was collected 
and transferred to a new Eppendorf tube and mixed with 40 µl Protein A sepharose-beads 
and an appropriate amount of the antibody. The samples were rotated at 4°C over night. 
The next day, the beads were washed 5 times by centrifuging 2 minutes at 8.000 rpm in 
an Eppendorf centrifuge, adding 1 ml 1× PBS and rotating 10 minutes at 4°C. Thereafter, 
the beads were mixed with loading buffer, the samples were put at 95°C for 5 minutes 
and cooled on ice.  
 
2.8.8. SDS-PAGE and detection 
 
Fixing solution: 
Acetic acid 10% 
Methanol 30% 
 
Enhancer: 
EN3HANCE Autoradiography enhancer from Perkin Elmer 
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To collect the beads at the bottom of the tube, they were quickly spun down and the 
supernatants were loaded onto a SDS-gradient gel to separate the proteins. As a protein 
standard, NEC-811 protein molecular weight markers [methyl-14C] methylated from 
PerkinElmer was used.  
After running the gel, it was incubated for 30 minutes in fixing solution, followed by 
another 30 minutes in enhancer gently shaking. Thereafter, the gel was rinsed 5 times 
with water and shaked for 25 minutes in water.  
Then the gel was applied onto a Whatman paper and dried for 1 hour and 40 minutes at 
80°C in a vacuum gel dryer. The gel was put into an exposure cassette and Amersham 
HyperfilmTM MP films from GE Healthcare were exposed to the signal at -80°C for 
several days to weeks. 
 
 
2.9. Histological methods 
 
2.9.1. Paraffin sections 
 
4% paraformaldehyde (PFA): 
PFA 4% 
Dissolved in ddH2O at 55-60°C 
pH 7.4 
 
Blocking solution: 
BSA    1% 
Inactivated goat serum 3% 
Dissolved in 1× PBS 
 
Freshly isolated tissue was incubated over night in 4% PFA at 4°C. The next day, the 
tissue was washed twice with 1× PBS for 10 minutes. Then, it was incubated in 50% 
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ethanol at room temperature for 1 hour. After this, the tissue was put into embedding 
cassettes and into the embedding machine Shandon Excelsior over night.  
Next day, the tissue was embedded in paraffin and stored at 4°C.  
The embedded tissue was cut with the LeicaRM2155 microtom into sections of 8 µm and 
fixed on PolysineTM slides (Menzel-Glaeser). The sections were dried over night at 37°C 
or for 1 hour at 50°C. To deparaffinize the tissue the slides were incubated for 20 minutes 
in XEM-200 gently shaking followed by 100%, 90%, 70%, 50%, 30% ethanol 2 minutes 
each and finally 3% H2O2 for 5 minutes.  
 
For Biotin-staining, the sections were incubated with blocking solution at room 
temperature for 1 hour. The primary antibody and the corresponding pre-immune serum 
were diluted with blocking solution and applied to the sections followed by an incubation 
at 4°C over night in a humid chamber.  
Next day, the slides were washed three times for 10 minutes with 1× PBS. The secondary 
biotinylated goat-anti-rabbit antibody was diluted with blocking solution and the sections 
were incubated with it for 1 hour at room temperature. Then, the slides were washed 
another 3 times for 10 minutes with 1× PBS. Thereafter, the sections were covered with 
Streptavidin-HRP diluted with 1% BSA in 1× PBS and incubated at room temperature for 
20 minutes. After three final washes of 10 minutes each with 1× PBS, the sections were 
covered with AEC+ Substrate-Chromogen, ready-to-use solution from Dako to get the 
color reaction. This color reaction was stopped with water, the slides were air-dried, 
mounted with Glycergel® Mounting Medium from Dako and stored at 4°C.  
 
2.9.2. Cryosections 
 
Frozen tissue was embedded in O.C.T.TM Compound Tissue-Tek® from Sakura at -24°C. 
Sections of 7 µm were cut with the HM500OM Microm and fixed on SuperFrost® Plus 
slides (Menzel-Glaeser). Then the slides were stored at -20°C.  
 
For specific detection of proteins, the sections were put at room temperature for 10 
minutes, followed by incubation in ice-cold aceton-methanol 1:1 gently shaking for 5 
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minutes. Thereafter, the slides were washed 3 times with 1× PBS for 5 minutes each. 
DakoCytomation Pen was used to draw a barrier to liquids. Then, the slides were 
incubated with the appropriate primary antibody diluted with 1× PBS over night at 4°C in 
a humid chamber.  
 
Biotin: 
After rinsing the slides 3 times 5 minutes each in 1× PBS, they were incubated with the 
secondary biotinylated goat-anti-rabbit antibody from Sigma diluted 1:500 with 1× PBS 
for 1 hour at room temperature. Subsequently, the slides were washed another 3 times 5 
minutes in 1× PBS followed by incubation with Streptavidin Peroxidase Polymer from 
Sigma diluted 1:250 with 1× PBS. After three final washes of 5 minutes each with 1× 
PBS, the sections were covered with AEC+ Substrate-Chromogen, ready-to-use solution 
from Dako to get the color reaction. This color reaction was stopped with water, the 
slides were air-dried, mounted in Glycergel® Mounting Medium from Dako, stored at 
4°C and analyzed by light microscopy.  
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2.10. Cell and Tissue Culture 
 
2.10.1 Isolation of endodermal epithelial cells (EECs) 
 
Hanks´ balanced salt solution (HBSS): 
CaCl2 (anhydrous)  0.14 g/ l 
KCl   0.40 g/ l 
KH2PO4  0.06 g/ l 
MgCl2•6H2O  0.10 g/ l 
MgSO4•7H2O  0.10 g/ l 
NaCl   8.00 g/ l 
NaHCO3  0.35 g/ l 
Na2HPO4•7H2O 0.09 g/ l 
D-glucose  1.00 g/ l 
The components were dissolved in ddH2O and the pH was adjusted to 6.0  
 
Wash solution:  
Horse serum 2% 
In HBSS 
 
Collagenase solution:  
Collagenase 235 U/ ml 
In wash solution 
 
Medium: 
DMEM with high glucose (4.5 g/ l), with D-Valine, without L-Valine, without L-
Glutamine from PAA    500 ml 
FCS      10% 
AB/AM antibiotic, antimyotic from Gibco 5 ml 
L-Glutamine 200 mM   5 ml 
Horse serum     2% 
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Endodermal epithelial cells were isolated from chick embryo yolk sacs of 8 to 10 days of 
incubation. First of all, the yolk sac was incubated in collagenase solution at 37°C for 4 
hours. Thereafter, the yolk sac was cut into 5 mm pieces and incubated again in 
collagenase solution for 10 minutes at room temperature with intermittent shaking. Large 
pieces were removed with forceps and the solution was transferred to a 50 ml tube. Wash 
solution was added to a final volume of 50 ml and the tube was inverted a few times. 
During an incubation time of 20 minutes at room temperature, the younger cells sank to 
the bottom of the tube, whereas the more lipid-loaded older cells floated. These floating 
cells were removed together with the supernatant and the cells. The cells at the bottom 
were washed two more times by adding 50 ml wash solution, incubating the solution at 
room temperature for 20 minutes and carefully removing the supernatant. Then, the cells 
were resuspended in 15 ml wash buffer and filtered through a 100 µm nylon mesh. 
Endodermal epithelial cells remained on the filter and were released with culture 
medium, which was transferred to a fresh 50 ml tube, where the cells were allowed to 
settle again. Finally, cells were plated at high concentration and low volume onto 
collagen-coated culture slides or nylon mesh and incubated at 37°C in 5% CO2. After 24 
hours a few drops of medium were added to each well and after 48 hours 0.5 ml of 
medium were added.  Then, the medium was changed every other day.  
 
2.10.2. Cysteine lyase activity-assay 
 
Reaction Solution: 
Tris/ HCl pH 8.5  0.15 M 
L-cysteine hydrochloride 10 mM 
Sodium sulfite  10 mM 
Lead acetate   1 mM 
Pyridoxal 5-phosphate 10 µM 
 
To verify the cultured cells being endodermal epithelial cells the cysteine lyase activity 
assay was performed.  
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First the cells were washed with 1× PBS. Then the cells were fixed for 5 minutes in 96% 
ethanol at 4°C, followed by a rinse in distilled water. Then the cells were incubated in 
reaction solution at 38°C for 90 minutes visualize cysteine lyase activity leading an 
insoluble brown precipitate.  
 
2.10.3. Tissue culture 
 
Medium: 
DMEM with high glucose (4.5 g/ l), with D-Valine, without L-Valine, without L-
Glutamine from PAA    500 ml 
FCS      10% 
AB/AM antibiotic, antimyotic from Gibco 5 ml 
L-Glutamine 200 mM   5 ml 
 
Yolk sacs were isolated from eggs of 15 to 18 days of incubation. Then, the yolk sacs 
were rinsed with HBSS to remove the yolk. Small pieces of 0.7 to 1 cm2 were cut off and 
incubated in medium, which was changed every day.  
After one week, most yolk was removed and the tissue pieces could be used for further 
experiments.  
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3. Results  
 
 
3.1. Expression of MTP in chicken extraembryonic tissue 
 
During my diploma thesis, the tissue of major interest was the chicken yolk sac. The yolk 
sac is one of the three extraembryonic tissues and is responsible for the supply of the 
embryo with nutrients from the yolk. It is supposed to take up lipids and re-synthesize 
them before their release into the embryonic blood system. As MTP is required for the 
synthesis of apoB-containing lipoproteins, I wanted to know, if and at which times it is 
expressed during embryonic development of the chicken.  
 
3.1.1. Western blot analysis 
 
First, membrane protein extracts of yolk sacs of different developmental stages (day 5, 
10, 15, and 20) were prepared, the proteins were separated by SDS-PAGE, and 
transferred to a nitrocellulose membrane. For the detection of MTP, an antibody, termed 
αMTP-B, directed against the C-terminal aa 879 to 893 of the chicken pre-protein was 
used. (Described in detail in Materials and Methods, 2.8.5) 
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First, I determined that MTP expression in the yolk sac starts between day 5 and day 10 
of embryonic development. To specify the point in time when MTP expression starts, and 
to visualize the supposed continual increase of MTP expression, further membrane 
protein extracts of intermediate developmental stages (day 7, 9, 11, and 13) were 
prepared. As the yolk sac is still present during the first days after hatching and also 
fulfilling a function, yolk sacs of 1- and 3-day-old chicks were included in my analyses.  
 
My results show that expression of MTP starts around day 7 of embryonic development. 
This is exactly after the first trimester, when the yolk sac starts to undertake the task of 
nourishing the embryo. Further, I could observe that MTP expression increases until day 
20, one day before hatching and it is reduced thereafter, when the yolk sac still has a 
nourishing function, but already starts to shrivel. (Figure 3.1) 
 
Figure 3.1. Western blot analysis of MTP expression in the chicken yolk sac.  
10 µg protein of membrane protein extracts from yolk sacs of 5-day-old chicken embryos to 3-
day-old chicks and from the liver of laying hen, used as a positive control, were used for 10% 
SDS-PAGE followed by western blot analysis. MTP was detected using the αMTP-B antibody 
directed against a C-terminal peptide of the pre-protein, diluted 1:5000. The intensity of the band 
increases with age of the embryo. At day 20, the expression of MTP in the yolk sac peaks and it 
decreases rapidly after hatching.  
 
Quantification with AlphaEaseFC led to more detailed information about the amount of 
MTP expressed in the yolk sac compared to the liver of laying hen, which served as a 
standard in western blots. The continuous increase of MTP expression towards day 20 of 
embryonic development and its decrease thereafter is clearly visible in the diagram 
(Figure 3.2). The decrease of the amount of detectable MTP after hatching could be due 
to degradation or a lower translation rate. 
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Figure 3.2. Quantification of MTP expression in the yolk sac with AlphaEaseFC.  
At day 5 of embryonic development, MTP expression could not be detected, but from around day 
7 on, it is present in the chicken yolk sac. The level of MTP expression massively increases 
resulting in a peak around day 20 (blue), showing an expression, twice as high as in the liver of the 
laying hen (pink).  
 
3.1.2. Quantitative PCR 
 
After analysis of MTP expression at the protein-level, I also wanted to analyse the 
transcript levels of MTP mRNA in the yolk sac. This was performed via quantitative 
PCR. After isolation of total RNA from yolk sacs of different developmental stages, 
cDNA was synthesized and used as a template for the quantitative PCR (for details see 
Materials and Methods 2.6.9). 
At the mRNA level, similar results as at the protein level could be observed (Figure 3.3). 
The amount of MTP mRNA decreases considerably after hatching as well, indicating that 
MTP mRNA is no longer required in such huge amounts at this time. This could be due 
to a down-regulation of the MTP gene transcription. 
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Figure 3.3. Course of MTP transcript levels in the yolk sac of chicken embryos and 
hatchlings.  
Similar to the protein level, the amount of transcripts peaks shortly before hatching, but decreases 
rapidly thereafter.  
 
qPCR and western blot analysis confirmed the presence of MTP mRNA and protein in 
the yolk sac from the end of the first trimester of embryonic development on, suggesting 
that the amounts of mRNA as well as protein peak around day 20, shortly before 
hatching. The fact that most of the nutrients stored in the yolk are taken up during the 
third trimester supports the suggestion that most MTP, crucial for lipoprotein synthesis, is 
required during this period of development.  
 
3.1.3. Immunohistochemistry 
 
It may be assumed that the re-synthesis of lipoproteins occurs at the inner cell layer of the 
yolk sac, which faces the yolk and is constituted by EECs. As shown before by qPCR and 
western blot analysis, MTP is expressed in the yolk sac. To localize MTP in the yolk sac 
at an ultrastructural level I performed immunohistochemistry. Cryosections were the 
method of choice because of the possibility to freeze the whole yolk sac together with the 
yolk. Using this technique, I was able to generate sections showing the yolk sac 
membrane with its two cell layers (mesoderm and EECs) and the yolk (Figure 4.A).  
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Figure 3.4 shows two representative immunohistochemically stained cryosections from 
the yolk sac of a 15-day-old chicken embryo. A significant reddish-brown coloring 
indicating the expression of MTP is present in the yolk sac. According to the staining 
obtained, the EECs, directly facing the yolk, clearly express MTP, but also the outer layer 
of the yolk sac, the mesoderm, appears to have a slightly reddish-brown coloring. To 
clarify the question, whether MTP is indeed expressed in the EECs, and whether apoB de 
novo synthesis occurs therein, these cells were isolated from yolk sacs.  
 
 
 
 
Figure 3.4. MTP expression in cryosections of the yolk sac of a 15-day-old chicken embryo.  
A and C: Detection of MTP with the αMTP-B antibody diluted 1:100. Picture C shows an 
invagination of the yolk sac, which is formed to enlarge its absorptive surface. The reddish-brown 
staining obtained by the use of biotinylated secondary antibody marks MTP, which is obviously 
present in the EECs. B and D: Preimmune serum was used instead of the primary antibody as a 
negative control. 
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3.1.4. Cell culture of and MTP expression in EECs 
 
MTP expression starts at the end of the first trimester of chicken embryonic development 
and peaks towards the end of the last one. Isolation and culturing of EECs works best 
around day 9 of embryonic development, due to the yet little amount of lipid droplets 
present at this stage (Figure 3.5). EECs from older yolk sacs, which already show a 
higher expression level of MTP, are massively lipid-laden and therefore cannot settle 
down and adhere onto the culture dish.  
 
    
Figure 3.5. Cultured EECs from yolk sacs of 8- to 10-day-old chicken embryos.  
A and B: EECs after 5 days in culture. B: Cysteine lyase activity assay: The presence of cysteine 
lyase activity and the resulting brown insoluble precipitate proove that the cultured cells actually 
are EECs.  
 
I improved the method of preparing isolated cells from yolk sac and provided evidence 
that the cultured cells are in fact EECs, but due to time constraints these cells could not 
be used for further investigations. Another approach used was organ culture of yolk sacs 
to show the potential de novo synthesis and secretion of apoB by the yolk sac.  
 
3.1.5. Organ culture and pulse chase analysis 
 
Yolk sac pieces of 0.25 cm2 size were cultured and used for pulse chase experiments. 
Newly synthesized apoB100 was immunoprecipitated from the conditioned medium after 
metabolic labeling and further subjected to SDS-PAGE. Exposition of films to the 
radioactively labeled proteins led to the findings that of apoB100 is indeed synthesized 
and secreted by cultured yolk sac pieces, although apparently only small amounts (Figure 
A B 
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3.6.). Compared to LMH-cells, a chicken hepatoma cell line that produces apoB-
containing lipoproteins (kindly provided by Prof. Dr. N.E. Ivessa), used as a positive 
control, the quantity of newly synthesized and secreted apoB100 is rather minute, but it 
cannot be excluded that this might be due to methodic reasons. An optimization of this 
experiment would be useful to clarify the question of apoB100 de novo synthesis by the 
yolk sac. Nevertheless, my results indicate that apoB100 is synthesized in vitro by the 
yolk sac.  
 
 
Figure 3.6. Pulse chase analysis with cultured yolk sac pieces.  
The yolk sac of a 15-day-old embryo was used for organ culture followed by pulse chase analysis 
and immunoprecipitation of apoB100. Cultured LMH-cells, provided by Prof. Dr. N.E. Ivessa, 
were used as a positive control. After 1 hour of chase, a weak signal corresponding to apoB is 
visible, becoming more intensive after 4 hours of chase phase.  
 
3.1.6. EEC cell lysate 
 
To demonstrate the expression of MTP in the inner cell layer of the yolk sac, a total cell 
lysate of isolated EECs of a 9-day-old chicken embryo was prepared, which was further 
used for western blot analysis. The proteins of the cell lysate from the EECs and 
membrane protein extracts from the liver of laying hen and the yolk sac of a 9-day-old 
chicken embryo as controls were separated by SDS-PAGE. According to protein 
concentrations determined by the Bradford assay, equal amounts of protein of each 
→ 
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extract were loaded onto the gel. As the EEC cell lysate is a total protein extract, the 
amount of MTP in this cell lysate is much lower than in membrane protein extracts of 
liver and yolk sac.  
 
 
Figure 3.7. Western blot analysis of MTP expression in EECs.  
50 µg protein of membrane protein extracts (LH liver, 9d embryo YS) and cell lysate (9d embryo 
EECs) were loaded onto a 10% gel and separated by SDS-PAGE. After transfer of the proteins to 
a nitrocellulose membrane, MTP was detected with the αMTP-B antibody. MTP is expressed in 
the EECs. The signal obtained in the lane of 9d embryo EECs is much weaker compared to the 
one of 9d embryo YS. This may be due to the different methods used for preparation of the protein 
extracts.  
 
By the use of the EECs for making a cell lysate, followed by separation of the proteins, 
western blot analysis and detection of MTP with a specific antibody, I could verify the 
presence of MTP in these cells (Figure 3.7). It remains to be excluded, however, that 
MTP is also expressed in the outer layer of the yolk sac, the mesoderm.  
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3.2. Expression of MTP in chicken embryonic tissues 
 
It is known that MTP is expressed in liver, small intestine, and kidney of the laying hen. 
Therefore, these tissues of the chicken embryo and hatchling were also targets of my 
investigations. Due to technical reasons, it is not possible to isolate these organs before 
day 10 of embryonic development (not yet well-defined and very small). This is the 
reason, why it was not possible to include liver, small intestine and kidney before day 10 
of chicken embryonic development in my experiments.  
 
3.2.1. Liver 
 
3.2.1.1. Western blot analysis 
 
Membrane protein extracts of embryonic and adult chicken liver were used to detect 
MTP therein, using the specific αMTP-B antibody. As shown in Figure 3.8, MTP is 
already expressed on day 10 of embryonic development at nearly the same level as in the 
liver of the laying hen.  
 
 
Figure 3.8. Western blot analysis of MTP expression in liver.  
10 µg protein of membrane protein extracts of liver of different developmental stages were 
subjected to a 10% SDS-PAGE, western blot analysis, and detection of MTP using the αMTP-B 
antibody. The expression of MTP in liver increases towards the end of embryonic development, 
followed by a decrease after hatching. Interestingly, the level of MTP expression in liver on day 
10 of embryonic development is almost the same as in the liver of laying hen.  
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Quantification with AlphaEaseFC gave more precise insight into the amounts of MTP 
expressed at the different developmental stages. Granted that the expression of MTP in 
the liver of laying hen is 1, its expression level in 10-day-old embryos is 0.95 fold. The 
level of MTP increases until the end of embryonic development, reaching a 1.46 fold 
level on day 15 and even a 2.33 fold one on day 20 compared to the amount of MTP in 
the laying hen’s liver. In the 1-day-old hatchling the expression level is 1.83 times higher 
and in the 3-day-old one 1.49 times, nearly the same as in the 15-day-old embryo.  
 
3.2.1.2. qPCR  
 
I also analyzed MTP mRNA levels in liver of different developmental stages. The 
correlation between protein expression and mRNA level in liver is not that defined as in 
the yolk sac. The maximum level of mRNA could be detected on day 15 of embryonic 
development, whereas on day 20 the amount of MTP mRNA is already lower and 
decreases strongly after hatching, reaching again a higher level in the liver of the full-
grown laying hen (Figure 3.9).  
 
 
Figure 3.9. Course of MTP transcript levels in the liver of chicken embryos, hatchlings, and 
laying hen.  
In contrast to the protein level of MTP in liver, which peaks on day 20, the mRNA level reaches 
its maximum already earlier, i.e. on day 15, suggesting different mechanisms of translational 
regulation in yolk sac and liver.  
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Interestingly, the MTP transcript level in the liver of 10-day-old chicken embryos is 
already much higher than in the one of laying hens. This leads to the suggestion that MTP 
mRNA and protein are already present in liver or primordial hepatocytes before day 10 of 
embryonic development, possibly from the beginning of the second trimester on (as it is 
the case in the yolk sac).  
 
3.2.1.3. Immunohistochemistry 
 
Immunohistological analysis should provide further evidence for the presence of MTP in 
embryonic liver. Paraffin sections were made and the primary αMTP-B antibody was 
used for detection of the protein.  
 
  
Figure 3.10. MTP expression in paraffin sections of the liver of a 17-day-old chicken embryo.  
A: Detection of MTP with the αMTP-B antibody diluted 1:100. The reddish-brown staining shows 
that MTP is expressed in embryonic liver. B. Preimmune serum was used instead of the specific 
antibody as a negative control.  
 
As can be seen in Figure 3.10.A, using the αMTP-B antibody for the detection, MTP is 
expressed in embryonic liver. This is in accordance to the results obtained by western 
blot analysis and quantitative PCR.  
 
 
 
 
 
 
A B 
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3.2.2. Small intestine  
 
3.2.2.1. Western blot analysis 
 
Membrane protein extracts of the small intestine of chicken embryos and hatchlings were 
used to investigate the presence of MTP in this tissue. MTP expression in the small 
intestine seems to start shortly before hatching, and reaches a much higher level in the 
small intestine of the laying hen than in its liver (Figure 3.11).  
 
 
Figure 3.11. Western blot analysis of MTP expression in small intestine.  
10 µg of membrane protein extracts of small intestine of different developmental stages and of 
liver of the laying hen were subjected to a 10% SDS-PAGE and western blot analysis using the 
αMTP-B antibody. The expression of MTP obviously starts shortly before hatching, when the 
chick starts with oral uptake of albumen. In the laying hen, the level of MTP expression in small 
intestine is significantly higher than in the liver.  
 
Quantification with AlphaEaseFC showed that the expression of MTP in the small 
intestine starts in the 20-day-old embryo at a 0.38 fold level compared to the level in the 
liver of the laying hen. This expression level increases rapidly reaching a around 1.2 fold 
higher expression in the 1- and 3-day-old chick. In the laying hen, the expression of MTP 
in small intestine is even 2.4 times higher than in the liver.  
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3.2.2.2. qPCR 
 
Analysis of MTP mRNA levels in small intestine of chicken embryos, chicks and laying 
hen showed that in the 15-day-old embryo, the amount of MTP mRNA in the small 
intestine is still very low followed by a dramatic increase towards the 20-day-old embryo. 
Interestingly, the protein level at this time point is still very low, although the mRNA 
level is higher than in the small intestine of the laying hen. This is another indication for 
the post-transcriptional regulation of MTP expression or a low translation rate. In the 
hatchling, the MTP mRNA level decreases and reaches a higher level again in the laying 
hen (Figure 3.12).  
 
 
Figure 3.12. Course of MTP mRNA levels in the small intestine of chicken embryos, 
hatchlings, and laying hen.  
On day 20 of embryonic development, high amounts of MTP mRNA are present in the small 
intestine. This high level of MTP mRNA is not maintained, it decreases rapidly in the hatchling 
and returns to a higher level in the laying hen again.  
 
3.2.2.3. Immunohistochemistry 
 
Western blot analysis showed that MTP is expressed in the small intestine of chicks from 
the day 20 of embryonic development on. Using paraffin sections of the small intestine of 
a 17-day-old chicken embryo, I could show that MTP is already expressed therein at this 
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time point of development. A slight reddish-brown staining is visible in the villi of the 
small intestine (Figure 3.13).  
 
    
Figure 3.13. MTP expression in paraffin sections of the small intestine of a 17-day-old 
chicken embryo.  
A: MTP was detected using the αMTP-B antibody diluted 1:100. MTP is localized in the 
enterocytes lining the villi. B: Preimmune serum was used as a negative control.  
 
Interestingly, MTP could be detected in the small intestine of 17-day-old chicken 
embryos. Using western blot analysis, there was no MTP expression detected in the small 
intestine of the 15-day-old embryo. In the small intestine of the 20-day-old chicken 
embryo, MTP could be detected. Obviously, MTP expression starts at the beginning of 
the third trimester of embryonic development. During this developmental period, the 
chicken embryo already orally takes up albumen. Therefore, the intestine already has to 
be functional, but its full set of skills is not developed until a few days after hatching.  
 
3.2.3. Kidney 
 
3.2.3.1. Western blot  
 
Membrane protein extracts from kidneys of chicken embryos, hatchlings, and laying hen 
were subjected to electrophoretical separation and western blot analysis using the αMTP-
B antibody. MTP is already expressed in kidney at the end of the second trimester of 
embryonic development, perhaps already earlier. The level of MTP increases 
continuously from the kidney of the 15-day-old embryo to the 3-day-old chick and 
A B 
 
 
 
 66 
probably also thereafter. However, the level of MTP in the kidney of laying hen is much 
lower than in the hatchlings (Figure 3.14).  
 
 
Figure 3.14. Western blot analysis of MTP expression in kidney.  
25 µg protein of membrane protein extracts of kidney of different developmental stages and of 
liver of the laying hen were separated using 10% SDS-PAGE and were subjected to western blot 
analysis using the αMTP-B antibody. The kidney of 15-day-old embryos already expresses MTP 
and its expression level increases also after hatching. The level in the kidney of the laying hen is 
much lower.  
 
This western blot was also analyzed with AlphaEaseFC. The expression level of MTP in 
the kidney of the 15-day-old embryo is about 0.22 fold of the one in the liver of laying 
hen. Although the expression level of MTP increases continuously in the developing 
kidney, at its maximum in the kidney of 3-days-old chicks, it only reaches a 0.88 fold 
level when compared to the liver of the laying hen. In the kidney of the laying hen, MTP 
expression level is even only the 0.29 fold of the MTP level in the liver.  
 
3.2.3.2. qPCR  
 
qPCR was also used to analyze MTP transcript levels in the kidney of chicken embryos, 
hatchlings, and laying hen. Already on day 10 of embryonic development, the level of 
MTP transcripts in the kidney is already higher than that in the one of the laying hen. On 
day 15, MTP mRNA level peaks and it continuously decreases thereafter (Figure 3.15). It 
appears that high levels of MTP expression in kidney are also important before and 
shortly after hatching, just as in liver and yolk sac.  
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Figure 3.15. Course of MTP mRNA levels in kidney of chicken embryos, hatchlings, and 
laying hen.  
MTP mRNA is already present in the kidney of 10-day-old chicken embryos. There is a dramatic 
increase towards day 15 and a quite rapid decrease thereafter. The MTP transcript level in the 
kidney of the laying hen is marginal compared to the MTP level therein of other developmental 
stages.  
 
3.2.3.3. Immunohistochemistry 
 
To confirm the presence of MTP in the embryonic kidney, I also did 
immunohistochemical stainings of kidneys derived from a 17-day-old chicken embryo. 
The reddish-brown staining can be clearly seen in this tissue (Figure 3.16.A). This is in 
accordance with the findings obtained by western blotting.  
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Figure 3.16. MTP expression in paraffin sections of the kidney of a 17-day-old chicken 
embryo.  
A: αMTP-B, diluted 1:100, has been used for the detection of MTP in the kidney. B: Preimmune 
serum was used as a negative control.  
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3.3. MTP mRNA and protein levels in various tissues at different 
developmental stages of the chicken 
 
Besides the course of MTP transcript and protein levels during embryonic development 
in yolk sac, liver, small intestine, and kidney, the amounts of MTP mRNA and protein, 
respectively, in these tissues was also of interest. Transcript levels were investigated 
using qPCR, protein expression was determined by western blotting and quantifications 
were performed with AlphaEaseFC.  
 
3.3.1. Transcript levels 
 
qPCR was performed (as described in Materials and Methods 2.6.9) using MTP primers 
for amplification of MTP transcripts in various tissues at different developmental stages. 
To enable the comparison of MTP transcript levels in different tissues, the values 
obtained were normalized to the housekeeping gene ggRS17 (encoding a chicken 
ribosomal protein). The normalized MTP transcript levels in different tissues are 
illustrated in Figure 17.  
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Figure 3.17. MTP transcript levels in various tissues of different developmental stages.  
The highest MTP transcript level is observed in the small intestine of the laying hen, followed by 
the yolk sac and the small intestine of the 20-day-old chicken embryo. The MTP mRNA levels are 
higher in embryonic liver, than in the adult one. The amounts of MTP transcripts in embryonic 
and adult kidney are marginal.  
 
As the liver of the laying hen served as an internal standard in every experiment, the 
normalized MTP transcript level therein is set 1. Compared with laying hen liver, the 
level in small intestine of the laying hen is 16 times higher and the one of the 20-day-old 
embryo is 4.7 times higher. In the yolk sac, the MTP mRNA level is also nearly 8 times 
higher than in the control tissue. Even in the embryonic liver, the MTP mRNA level is 
twice as high in the liver of the laying hen. In the kidney, the MTP transcript levels reach 
only a 0.2 fold level in the laying hen and a 0.4 fold in the 20-day-old embryo compared 
to the liver of the laying hen.  
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3.3.2. Protein levels  
 
At the protein level, the amount of MTP in different tissues was determined using 
AlphaEaseFC, based on western blot analysis. The values obtained were mostly similar to 
MTP transcript levels, but there were also some remarkable differences in some tissues.  
For example, in the small intestine of the 20-day-old embryo, the level of MTP mRNA 
reaches already a very high level, whereas protein expression starts around this time point 
at a still low level. In liver of the 20-day-old embryo, the amount of MTP mRNA is very 
low compared to its amount in the liver of the laying hen. At the protein level, the 
difference between the liver of the embryo and the full-grown animal is not that 
significant. (Figure 18.)  
 
 
Figure 3.18. MTP protein levels in various tissues of different developmental stages.  
At the protein level, the highest MTP expression exists in the small intestine of the laying hen. In 
contrast to the MTP transcripts, there is a quite high protein level in the liver of the 20-day-old 
embryo and the level of MTP in the small intestine of the 20-day-old embryo is very low. MTP is 
expressed at a nearly 2 times higher level in the yolk sac than in the liver of the laying hen. The 
expression of MTP in kidney is only half as high in the 20-day-old embryo and even lower in the 
laying hen.  
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4. Discussion 
 
 
MTP plays a major role in the formation of apoB-containing lipoproteins and therefore it 
is an indispensable protein in lipid metabolism. In humans, MTP is expressed mainly in 
the liver and small intestine, but also in kidney, ovary, and testis (Shoulders et al. 1993). 
Later studies showed that MTP is also expressed in human yolk sac and placenta 
(Madsen et al. 2004). In mouse, MTP is also expressed in liver and small intestine of both 
embryos and adult animals, and in yolk sac (Nakamuta et al. 1996; Shelton et al. 2000). 
In the laying hen, MTP is present in liver, small intestine, and kidney, an organ, which 
plays a major role in chicken lipoprotein metabolism (Ivessa et al. in revision; Walzem et 
al. 1999).  
 
The presence of MTP in organs involved in lipid metabolism in the chicken and in the 
yolk sac of rodents and humans lead to the assumption that MTP might also be present in 
the yolk sac of chicken embryos, as well as in other tissues. The chicken embryo depends 
on the yolk sac because it nourishes on the nutrients and lipids present therein (Noble and 
Cocchi. 1990). Lipids have to be transported from the yolk to the growing embryo. This 
process requires proteins involved in lipid metabolism and transport (Speake et al. 1998). 
MTP probably forms part of the complex interplay of a multitude of proteins 
participating in the uptake, remodeling, and secretion of lipoproteins on their way from 
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the yolk to the embryonic circulation (Hermann et al. 2000). It is also supposed to play a 
role in chicken embryonic lipid metabolism in various organs. Therefore, my studies 
were focused on the role of MTP during chicken embryonic development.  
 
The chicken yolk sac was the tissue of major interest, as it is responsible for providing 
the growing embryo with nutrients that are required for development and growth. I could 
show that MTP is expressed in the chicken yolk sac from the end of the first trimester of 
embryonic development on (Figure 3.1). This result is similar to the findings of MTP 
mRNA expression in the mouse yolk sac. At day 9.5 of mouse embryonic development, 
which was the earliest time point examined, the yolk sac already showed stable MTP 
expression (Shelton et al. 2000).  
As can be seen in Figure 3.1 and 3.2, the amount of MTP in the chicken yolk sac 
increases continuously until the end of embryonic development and rapidly decreases 
after hatching. Due to the presence of apoB-fragments in the yolk and apoB100 in the 
embryonic blood system, it has been suggested that lipoproteins are re-synthesized in the 
yolk sac (Hermann et al. 2000) and the presence of MTP therein gives support to this 
hypothesis. The huge amount of MTP in the yolk sac during the third trimester of 
embryonic development probably is a consequence of the massive uptake of lipids and 
nutrients from the yolk sac during this time period (Speak et al. 1998).  
Similarly, MTP mRNA is present in the yolk sac and its amounts increase and decrease 
simultaneously with the protein levels, as shown in Figure 3.3. It appears that the MTP 
mRNA is translated rapidly without complex regulatory mechanisms that inhibit or delay 
the expression of functional MTP.  
 
Localization of MTP in the yolk sac was also of interest during my diploma thesis. It has 
been supposed that MTP is present and functional in the EECs (Hermann et al. 2000). 
These cells form the inner cell layer of the yolk sac, which is in direct contact with the 
yolk. Therefore, I wanted to verify the presence of MTP in this cell layer. This was done 
by cryosections (Figure 3.4) and also by western blot analysis of a cell lysate of isolated 
EECs (Figure 3.7). These two methods showed that MTP is present in the EECs. To 
investigate, whether MTP is involved in apoB-containing lipoprotein synthesis in this cell 
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layer of the yolk sac, primary cell culture of EECs was established. This is a very time-
consuming process, and therefore it could not be pursued extensively. There could, 
however, evidence be provided that the cultured cells are in fact EECs (Figure 3.5). To 
demonstrate, that the yolk sac also secretes apoB-containing lipoproteins, organ culture 
of yolk sac pieces was performed. Using pulse chase analysis, it could be show, that 
apoB100 is synthesized and secreted by the yolk sac, a process that requires MTP (Figure 
3.6).  
 
In the laying hen, MTP is expressed in liver, small intestine, and kidney (Ivessa et al. in 
revision). Therefore, embryonic liver, small intestine, and kidney were also tissues of 
interest for this study. Western blot analysis, quantitative PCR, and paraffin sections were 
used to analyze the expression of MTP in these tissues during chicken embryonic 
development.  
 
As shown in Figure 3.8, in the embryonic liver, MTP expression starts most likely around 
day 10 of chicken embryonic development. It cannot be determined definitely, at which 
time MTP expression starts, because it is not possible to isolate liver nor other organs of 
chicken embryos before day 10. As the expression level is already quite high in the liver 
of the 10-day-old chicken embryo (0.95 fold of the level observed in the liver of the 
laying hen), it is suggested that MTP expression starts already earlier, perhaps at the end 
of the first trimester of embryonic development, as it is the case in yolk sac. The level of 
MTP in the embryonic liver increases continuously until the end of embryonic 
development and decreases again after hatching. This is a very similar course of MTP 
expression compared to the one in the yolk sac.  
The liver is the major organ of lipid metabolism in the chicken. Lipoproteins, secreted 
from the yolk sac into the embryonic circulation, enter the embryo via the portal vein, 
first pass the liver, and then supply the other organs. Lipids not needed by the other 
organs, return to the liver and accumulate therein. As most lipoproteins and lipids enter 
the embryonic circulation during the third trimester of embryonic development, there is 
also the highest rate of their accumulation in the embryonic liver during this time period. 
The liver’s attempt to get rid of excess lipids may lead to a higher expression of MTP, 
 
 
 
 75 
trying to increase the formation of apoB-containing lipoproteins, and the subsequent 
higher secretion of lipids. (Noble and Cocchi. 1990)  
 
At the mRNA level, MTP is transcribed at a quite high level already in the liver of the 
10-day-old embryo (Figure 3.9). This level further increases until day 15 of embryonic 
development and decreases thereafter. Shortly after hatching, it even reaches a lower 
level than in the liver of the laying hen. The mRNA level of MTP in the liver peaks 
earlier in embryonic development than the protein level and it also decreases more 
drastically than the amount of protein. This could indicate that the MTP mRNA is 
somehow posttranscriptionally regulated in the embryonic liver.  
In the mouse, MTP mRNA is also expressed already at day 9.5 of embryonic 
development in the hepatic primordium. MTP expression also increases from thereon. 
(Shelton et al. 2000)  
Immunohistochemical analysis of MTP expression in chicken embryonic liver confirmed 
the presence of MTP in this tissue (Figure 3.10).  
 
Western blot analysis of protein extracts from chicken small intestine (Figure 3.11) 
showed that MTP is expressed therein from around day 20 of embryonic development on. 
Apparently, MTP expression in small intestine starts in the third trimester of embryonic 
development, when the chick starts with the oral uptake of albumen food. Interestingly, 
the expression level of MTP in the small intestine is already very high one day after 
hatching compared to the laying hen and in the laying hen, the level of MTP in the small 
intestine is a multiple of the one in the liver.  
In the small intestine of humans, MTP is involved in the synthesis of apoB48-containing 
lipoproteins (chylomicrons), but chicken lack this type of lipoprotein (Black 2007; Tarugi 
et al. 1990). It is, however, possible that MTP in small intestine is required for the 
assembly of so-called portomicrons. These are intestinally derived lipoproteins, which 
carry apoB100 (Steinmetz et al. 1998).  
At the mRNA level, it was determined that MTP is transcribed already before hatching in 
the small intestine. Little amounts of MTP transcripts can already be detected in the small 
intestine of the 10-day-old chicken embryo. At day 15 of embryonic development, the 
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MTP mRNA level peaks and decreases thereafter, reaching again a somewhat higher 
level in the laying hen. (Figure 3.12) As in the liver, it could be that MTP is regulated 
post-transcriptionally.  
In mouse, MTP mRNA has been detected in the small intestine of embryos at 
developmental stage 12.5. At developmental stage 16.5, MTP expression is strongly 
upregulated in the small intestine and maintains a high level also post-natal and during 
adulthood. (Shelton et al. 2000)  
Using immunohistochemistry, it could be shown, that MTP is present in small amounts in 
the villi of the small intestine of 17-day-old chicken embryos (Figure 3.13).  
 
The avian kidney is also involved in lipid metabolism (Walzem et al. 1999). As MTP is 
expressed in the kidney of the laying hen, the embryonic kidney was also of interest for 
my study. I could show that MTP is expressed at day 15 and later on in the embryonic 
kidney, perhaps already earlier. It is not possible to determine the exact time point when 
MTP expression starts, due to the small size of embryonic kidney. Interestingly, the 
course of MTP expression in the kidney is quite different to the ones in yolk sac and 
liver. The MTP level in the kidney continuously increases from day 15 of embryonic 
development to the 3-day-old chick. In the kidney of the laying hen, MTP is expressed at 
a lower level again. (Figure 3.14)  
At the mRNA level, the highest amount of MTP transcript in the kidney was observed at 
day 15 of chicken embryonic development, and it decreases dramatically thereafter, as 
can be seen in Figure 3.15. This is quite in contrast to the course of MTP expression in 
the kidney, but as the level of MTP in the kidney is very low compared to the other 
tissues where this protein is expressed, it might be regulated differently in the kidney 
leading to a large time interval between transcription and translation.  
In mouse embryos, neither in early developmental stages nor in later ones MTP mRNA 
could b detected (Shelton et al. 2000).  
Immunohistochemical analysis of chicken embryonic kidney emphasized the presence of 
MTP therein and also supports the notion that MTP plays a role in this organ (Figure 
3.16).  
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To compare the amounts of MTP protein and mRNA in the different tissues to each other, 
western blot analysis and quantitative PCR experiments were performed. At the mRNA 
level, the highest level of MTP transcripts is observed in the small intestine of the laying 
hen. Compared to this transcript level, the amount of MTP mRNA in the liver and the 
kidney of the laying hen are marginal. (Figure 3.17)  
Similar results were obtained in the mouse. Around embryonic developmental stage 16.5, 
the MTP mRNA level in the liver surmounts the level in the small intestine. From there 
on, the higher MTP level in the small intestine is maintained until post-natal day 1.5 and 
also in adulthood. (Shelton et al. 2000)  
In the 20-day-old chicken embryo, the highest level of MTP transcript is present in the 
yolk sac, followed by the small intestine, liver, and finally kidney. The difference 
between the levels in the different tissues is not that high in the embryo when compared 
to the same tissues in the laying hen. (Figure 3.17)  
 
At the protein level, a similar distribution of MTP is observed in the different organs of 
the laying hen compared to the mRNA levels in the respective tissues. The highest level 
of MTP protein in the laying hen is detected in the small intestine, followed by the liver 
and the kidney. In the 20-day-old embryo, the situation is somewhat different at the 
protein level compared to the MTP mRNA level. The highest level of MTP is found in 
the liver, followed by the yolk sac. The smallest amounts of MTP are present in the 
kidney and the small intestine of the 20-day-old chicken embryo. (Figure 3.18)  
 
The results of this study clearly showed that MTP is expressed during chicken embryonic 
development in liver, kidney, small intestine, and yolk sac. Expression of MTP starts in 
the yolk sac presumably at the end of the first trimester of embryonic development. It 
could be shown that MTP is expressed in liver and in kidney shortly later. It cannot be 
determined, whether MTP is expressed in these organs already at an earlier 
developmental stage, because isolation of organs earlier in embryonic development is not 
possible. MTP expression in the small intestine starts around day 17 of embryonic 
development. Studies with mice showed a similar expression profile of MTP in yolk sac, 
liver, and small intestine. Initially, MTP expression starts in the mouse yolk sac, followed 
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by the primordial liver and subsequently in the developing small intestine (Shelton et al. 
2000). MTP in the yolk sac is supposed to be involved in apoB re-synthesis (Hermann et 
al. 2000), and the findings of this study also give support to this suggestion. Liver, small 
intestine, and kidney are organs involved in lipid-metabolism, and therefore also require 
functional MTP, especially during embryonic development.  
 
Future plans to extend this study include cultivation of primary EECs. It should then be 
possible to determine if these particular cells re-synthesize and secrete apoB100-
containing lipoproteins. These cells could also be used for immunofluorescent staining of 
MTP and other proteins involved in uptake, degradation, and re-synthesis of lipoproteins 
to localize this process. Cryosections of the yolk sac stained with a fluorescently labeled 
secondary antibody could give information about the exact localization of MTP in 
polarized EECs. As MTP is involved in apoB biogenesis, it could be that it is localized in 
the ER close to the basal side of the EECs, where apoB is secreted to the embryonic 
blood system, rather than near the apical cellular membrane.  
To investigate whether MTP in liver and kidney is expressed already before day 10 of 
embryonic development, cryosections of chicken embryos could be used to detect MTP 
in these organs.  
As the protein level of MTP in the 3-day-old chick in liver, small intestine, and kidney is 
not the same as in the laying hen, it would also be quite interesting, at which time point of 
development, the expression level of MTP adjusts to its final level. This might occur 
shortly after hatching, or later on during sexual maturation, as estrogen and testosterone 
influence lipid metabolism. On the other hand, there has no effect of estrogen been found 
on the level and activity of MTP in mature animals and in a cell culture system using 
LMH-2A cells (Ivessa et al. in revision). Further, it would be interesting to study the 
influence of sex-specific hormones on MTP expression, especially during the laying 
period of laying hens compared to roosters.  
 
 
 
 
 
 
 
 79 
 
 
 
 
 
 
 
Bibliography 
 
 
Black, D.D. 2007. Development and physiological regulation of intestinal lipid 
absorption. I. Development of intestinal absorption: cellular events in chylomicron 
assembly and secretion. Am. J. Physiol. Gastrointest. Liver. Physiol. 293: G519-G524  
Dixon, J.L., S. Furukawa, and H.N. Ginsberg. 1991. Oleate stimulates secretion of 
apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early 
intracellular degradation of apolipoprotein B. J. Biol. Chem. 266: 5080-5086  
Gordon, D.A. and H. Jamil. 2000. Progress towards understanding the role of microsomal 
triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Bichim. 
Biophys. Acta 1486: 72-83  
Hagan, L.H., B. Kienzle, H. Jamil, and N. Hariharan. 1994. Transcriptional regulation of 
human and hamster microsomal triglyceride transfer protein genes. J. Biol. Chem. 
269: 28737-28744  
Hermann, M., M.G. Mahon, K.A. Lindtedt, J. Nimpf, and W.J. Schneider. 2000. 
Lipoprotein receptors in extraembryonic tissues of the chicken, J. Biol. Chem. 275: 
16837-16844  
 
 
 
 80 
Herz, J. and R.V. Farese, Jr. 1999. The LDL receptor gene family, apolipoprotein B and 
cholesterol in embryonic development. J. Nutr. 129: 473S-475S  
Hussain, M.M. and A. Bakillah. 2008. New approaches to target microsomal triglyceride 
transfer protein. Curr. Opin. Lipid. 19:572-578 
Hussain, M.M., J. Iqbal, K. Anwar, P. Rava, and K. Dai. 2003. Microsomal triglyceride 
transfer protein: a multifunctional protein. Front. Biosci. 8: 500-506  
Hussain, M.M., J. Shi, P. Dreizen. 2003. Microsomal triglyceride transfer protein and its 
role in apoB-lipoprotein assembly. J. Lipid Res. 44:22-32  
Hussain, M.M., P. Rava, X. Pan, K. Dai, S.K. Dougan, J. Iqbal, F. Lazare, and I. Khatun. 
2008. Microsomal triglyceride transfer protein in plasma and cellular lipid 
metabolism. Curr. Opin. Lipid. 19: 277-284  
Ivessa, N.E., E. Rehberg, B. Kienzle, F. Seif, R. Hermann, M. Hermann, W.J. Schneider, 
and D.A. Gordon. 2009. Molecular cloning, expression and hormonal regulation of 
the chicken microsomal triglyceride transfer protein, in revision  
Lin, M.C.M., C. Arbeeny, K. Bergquist, B. Kienzle, D.A. Gordon, and J.R. Wetterau. 
1994. Cloning and regulation of hamster microsomal triglyceride transfer protein. J. 
Biol. Chem. 269: 29138-29145  
Madsen, E.M., M.L.S. Lindegaard, C.B. Andersen, P. Damm, and L.B. Nielsen. 2004. 
Human placenta secretes apolipoprotein B-100-containing lipoproteins. J. Biol. 
Chem. 279: 55271-55276  
Moestrup, S.K. and L.B. Nielsen. 20005. The role of the kidney in lipid metabolism. 
Curr. Opin. Lipidol. 16: 301.306  
Moran, E. T. Jr. 2007. Nutrition of the developing embryo and hatchling. Poult. Sci. 86: 
1043-1049  
Noble, R.C. and M. Cocchi. 1990. Lipid metabolism and the neonatal chicken, Prog. 
Lipid Res. 29: 107-140  
 
 
 
 81 
Nakamuta, M., B.H. Chang, R. Hoogeveen, W.H: Li, L. Chan. 1996. Mouse microsomal 
triglyceride transfer protein large subunit: cDNA cloning, tissue-specific expression 
and chromosomal localization. Genomics 33: 313-316  
Pan, M., J. Liang, E.A. Fisher, and H.N. Ginberg. 2002. The late addition of core lipids to 
nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-
rich lipoproteins, is independent of both microsomal triglyceride transfer protein 
acitivity and new triglyceride synthesis. J. Biol. Chem. 277: 4413-4421  
Raabe, M., L.M. Flynn, C.H. Zlot, J.S. Wong, M.M. Véniant, R.L. Hamilton, and S.G. 
Young. 1998. Knockout of the abetalipoproteinemia gene in mice: Reduced 
lipoprotein secretion in heterozygous and embryonic lethality in homozygous. Proc. 
Natl. Acad. Sci. 95: 8686-8691  
Shelness, G.S. and A.S. Ledford. 2005. Evolution and mechanism of apolipoprotein B-
containing lipoprotein assembly. Curr. Opin. Lipid. 16: 325-332  
Shelton, J.M., M. Lee, J.A. Richardson, and S.B. Patel. 2000. Microsomal triglyceride 
transfer protein expression during mouse development. J. Lipid Res. 41: 532-537  
Shoulders, C.C., D.J. Brett, J.D. Bayliss, T.M. Narcisi, A. Jarmuz, T.T. Grantham, P.R. 
Leoni, S. Bhattacharya, R.J. Pease, P.M. Cullen. 1993. Abetalipoproteinemia is 
caused by defects of the gene encoding the 97 kDa subunit of a microsomal 
triglyceride transfer protein. Hum. Mol. Genet. 2: 2109-2116 
Smolenaars, M.M.W., O. Madsen, K.W. Rodenburg, and D.J. van de Horst. 2007. 
Molecular diversity and evolution of the large lipid transfer protein superfamily. J. 
Lipid Res. 48: 489-502 
Speak, B. K., A.M.B. Murray, and R.C. Noble. 1998. Transport and transformations of 
yolk lipids during development of the avian embryo. Prog. Lipid Res. 37: 1-32 
Steinmetz, A., M. Hermann, J. Nimpf, R. Aebersold, A. Ducret, R.B. Weinberg, and W.J. 
Schneider. 1998. Expression and conservation of apolipoprotein AIV in an avian 
species. J. Biol. Chem. 273: 10543-10549  
Tarugi, P., L. Albertazzi, S. Nicolini, and S. Calandra. 1990. Absence of apolipoprotein 
B-48 in the chick, Gallus domesticus. J. Lipid Res. 31: 417-427  
 
 
 
 82 
Tarugi, P., S. Nicolini, L. Marchi, G. Ballarini, and S. Calandra. 1994. Apolipoprotein B-
100 production and cholesteryl ester content in the liver of developing chick. J. Lipid 
Res. 35: 2019-2031  
Tarugi, P., M. Averna, E. di Leo, A.B. Cefalù, D. Noto, L. Magnolo, L. Cattin, S. 
Bertolini, S. Calandra. 2007. Molecular diagnosis of hypobetalipoproteinemia: An 
ENID review. Atherosclerosis 195: e19-e27  
Terasawa, Y., S.J. Cases, J.S. Wong, H. Jamil, S. Jothi, M.G. Traber, L. Packer, D.A. 
Gordon, R.L. Hamilton, and R.V. Farese, Jr. 1999. Apolipoprotein B-related gene 
expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk 
sac during embryonic development. J. Lipid Res. 40: 1967-1977  
Walzem, R.L., R.J. Hansen, D.L. Williams, and R.L. Hamilton. 1999. Estrogen induction 
of VLDLy assembly in egg-laying hens. J. Nutr. 129: 467S-472S  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 83 
 
 
 
 
 
 
 
List of figures 
 
 
Figure 1.2. Structural and functional domains of the M-subunit of MTP. ....................... 11 
Figure 1.3. Lipid transfer activity. .................................................................................... 12 
Figure 1.4. ApoB binding activity. ................................................................................... 13 
Figure 1.5. Membrane binding activity............................................................................. 13 
Figure 1.6. Ovary and oviduct of the laying hen .............................................................. 21 
Figure 1.7. 10-day-old chicken embryo............................................................................ 22 
Figure 2.1. Genetic map of the pCR 2.1-TOPO cloning vector ....................................... 28 
Figure 3.1. Western blot analysis of MTP expression in the chicken yolk sac. ............... 53 
Figure 3.2. Quantification of MTP expression in the yolk sac with AlphaEaseFC.......... 54 
Figure 3.3. Course of MTP transcript levels in the yolk sac of chicken embryos and 
hatchlings. ................................................................................................................. 55 
Figure 3.4. MTP expression in cryosections of the yolk sac of a 15-day-old chicken 
embryo. ..................................................................................................................... 56 
Figure 3.5. Cultured EECs from yolk sacs of 8- to 10-day-old chicken embryos............ 57 
Figure 3.6. Pulse chase analysis with cultured yolk sac pieces. ....................................... 58 
Figure 3.7. Western blot analysis of MTP expression in EECs........................................ 59 
Figure 3.8. Western blot analysis of MTP expression in liver.......................................... 60 
 
 
 
 84 
Figure 3.9. Course of MTP transcript levels in the liver of chicken embryos, hatchlings, 
and laying hen. .......................................................................................................... 61 
Figure 3.10. MTP expression in paraffin sections of the liver of a 17-day-old chicken 
embryo. ..................................................................................................................... 62 
Figure 3.11. Western blot analysis of MTP expression in small intestine........................ 63 
Figure 3.12. Course of MTP mRNA levels in the small intestine of chicken embryos, 
hatchlings, and laying hen......................................................................................... 64 
Figure 3.13. MTP expression in paraffin sections of the small intestine of a 17-day-old 
chicken embryo......................................................................................................... 65 
Figure 3.14. Western blot analysis of MTP expression in kidney. ................................... 66 
Figure 3.15. Course of MTP mRNA levels in kidney of chicken embryos, hatchlings, and 
laying hen.................................................................................................................. 67 
Figure 3.16. MTP expression in paraffin sections of the kidney of a 17-day-old chicken 
embryo. ..................................................................................................................... 68 
Figure 3.17. MTP transcript levels in various tissues of different developmental stages. 70 
Figure 3.18. MTP protein levels in various tissues of different developmental stages. ... 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85 
 
 
 
 
 
 
 
List of tables 
 
 
Table 2.1. Properties of chemically competent E.coli TOP10 bacteria ............................ 27 
Table 2.2. Properties of T/A cloning vector ..................................................................... 28 
Table 2.3. List of oligonucleotide primers used for PCR ................................................. 29 
Table 2.4. List of anitbodies ............................................................................................. 30 
Table 2.5. Standard mixture of chemicals and enzymes used for PCR ............................ 31 
Table 2.6. Standard conditions used for PCR................................................................... 31 
Table 2.7. Standard mixture of chemicals and enzymes for qPCR .................................. 35 
Table 2.8. Standard program used for qPCR with chicken MTP primers. ....................... 36 
Table 2.9. Composition of SDS-gels ................................................................................ 40 
 
 
 
 
 
 
 
 
 
 
 
 
 86 
 
 
 
 
 
 
 
Abbreviations 
 
 
µg …………. microgram  
µl ………….. microliter  
A …………... adenine  
aa ………….. amino acid  
AEC ………. 3-amino-9-ethylcarbazole  
Amp……….. ampicillin  
apo ………… apolipoprotein  
APS ……….. ammoniumpersulfate  
AP-1 ………. activator protein 1 
bp …………. base pair  
BSA ……….. bovine serum albumin  
C …………... cytosine, Celsius  
C-terminal…. carboxy-termial  
cDNA ……..  complementary DNA  
CE ………… cholesterol ester 
CD1d ……… cluster of differentiation 1d  
d …………… day  
DMEM ……. Dulbecco´s Modified Eagle Medium 
 
 
 
 87 
DMSO …….. dimethylsulfoxide  
DNA ……… desoxyribonucleic acid  
DTT ……….. dithiothreitol 
dNTP ……… deoxyribonucleotide triphosphate  
EEC .............. endodermal epithelial cell 
ECL ……….. enhanced chemiluminescnence  
EDTA ……... ethylenediaminetetraacetic acid  
ER ………… endoplasmatic reticulum  
FCS ………... fetal calf serum  
fw …………. forward  
g …………… gram  
G …………... guanine  
gg ………….. Gallus gallus  
gge ……….... gauge  
h ………….... hour  
HBSS ……… Hanks´ balanced salt solution 
HDL ………. high density lipoprotein 
HMG ……… 3-hydroxy-3-methyl-glutaryl 
HNF ……….. hepatocyte-specific trans-factor  
HRP ……….. horse radish peroxidase  
int …………. intestine  
Kan ………... kanamycin  
kb .................. kilobase  
kDa ………... kilodalton  
l ……………. liter  
LB …………. Luria Bertani  
LDL ……….. low density lipoprotein  
LH ………… laying hen 
LLT ………... large lipid transfer  
LLTP ……… large lipid transfer protein 
LMH ………. leghorn male hepatoma 
 
 
 
 88 
LPL .............. lipoprotein lipase 
LXR .............. liver X receptor 
M ………….. molar  
mA ………… milliampere  
mg ………… milligram  
Mg ………… magnesium  
min ………... minute  
ml …………. milliliter  
mM ………... millimolar  
mRNA …….. messanger RNA 
MTP ………. microsomal triglyceride transfer protein  
M-subunit …. microsomal triyglyceride transfer protein-subunit  
N-linked ....... asparagine-linked  
nm ................ nanometer  
NK ……….... natural killer  
N-terminal … amino terminal 
N terminus … amino terminus 
OD ……….... optical density  
PAA ……….. polyacrylamide  
PAGE ……... polyacrylamide gelelecrophoresis  
PBS ……….. phosphate buffered saline  
PCR ……….. polymerase chain reaction  
PDI ………... protein disulfide isomerase  
PFA ……….. paraformaldehyde 
pmol ………. picomolar  
P-subunit ….. protein disulfide isomerase-subunit  
qPCR ……… quantitative PCR 
rev ……….... reverse  
RNA ………. ribonucleic acid  
RNase ……... ribonuclease  
rpm ………... rotations per minute  
 
 
 
 89 
RPMI ……… Roswell Park Memorial Institute 
sec …………. second  
SDS ……….. sodium dodecylsulfate  
SR-BI ........... scavenger receptor class B type I  
SRE ……….. sterol responsive element  
T …………... thymine, tween  
TBS ……….. tris bufferd saline  
TEMED ….... N,N,N,´N´ tetramethylethylendiamine  
Tris ………... trishydroxymethylaminomethan 
U ………....... unit  
UV ……….... ultraviolet  
V …………... volt  
VLDL ……... very low density lipoprotein  
Vtg ………... vitellogenin  
X-Gal …….... 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside  
YS ………… yolk sac 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 90 
 
 
 
 
 
 
 
Curriculum vitae 
 
 
Name: Christine Eresheim 
Family status:  unmarried, no children 
Date of birth:  July 19, 1985, Oberpullendorf, Autria 
Nationality:  Austria 
Current address:  Gumpendorferstraße 83-85/1/51, A-1060 Vienna 
Mobile:  +43 664 5066552 
E-mail:  christine.eresheim@gmx.at 
 
 
Education  
 
09. 2008 – 06. 2009 Master thesis at the Medical University of Vienna, Department 
of Medical Biochemistry, Dr. Bohrgasse 9, A-1030 Vienna. 
Subject: “Characterization of MTP during chicken embryonic 
development”  
 
10. 2003 – 11. 2008 Undergraduate Studies in Molecular Biology, Faculty of Life 
Sciences, University of Vienna, Austria 
 
 
 
 91 
 
Primary education  
 
06. 2003  School leaving examination “summa cum laude”  
 
09. 1995 – 06.2003 BG, BRG, BORG Oberpullendorf, Austria, with main focus on 
foreign languages  
 
09. 1991 – 06. 1995 Elementary school in Piringsdorf, Austria  
 
 
Employment  
 
07. 2004 – 08. 2007 Summer jobs at Bogner Veranstaltungs GmbH, Wiesen, 
Austria  
 
 
Language skills  German native language 
 English fluent oral and written 
Spanish oral and written 
French good knowledge 
 
 
Computer skills MS-Office 
Adobe Photoshop 
Online databases 
Experienced with the user interfaces of Mac OS X and 
Windows 
 
 
 
 
 
 
 92 
 
Scientific skills Detailed knowledge of microbial test methods 
 Detailed knowledge of RNA, DNA, and protein isolation and 
analysis 
 Skilled in the use of laboratory instrumentation related to 
microbiology, cellular, and molecular genetics  
 Skilled in performing scientific experiments and in interpreting 
the results  
 
